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BREAST IMPLANTS As BEAUTY RITUAL:
WOMAN'S SCEPTRE AND PRISON
By Julie M. Spanbauert
Taught from their infancy that beauty is woman ' sceptre, the mind
shapes itself to the body, and, roaming round its gilt cage, only seeks to
adorn its prison.tt
I. INTRODUCTION
In the past several years, various publications, including medical literature,
1
television reports, 2 newspaper articles, 3 and even a book written by a physician
and editor of a prestigious medical joumal,4 have delivered roughly the same
message to the public about silicone gel breast implants: they do not cause
disease. According to these publications, the issue is all but closed.5 They claim
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1. A recently released medical study allegedly demonstrating no increase in connective-tissue disease for
women with breast implants involved 87,501 women, 1183 of whom had breast implants; 876 of this latter
number had silicone gel implants. See J. Sanchez-Guerrero et al., Silicone Breast Implants and the Risk of
Connective-7issue Diseases and Symptoms, 332 NEw ENG. J. MED. 1666, 1666-67 (1995) [hereinafter
Nurses' Study]. An earlier, smaller study of 2247 women in Olmsted County, Minnesota, 749 of whom had
breast implants, found no increase in the targeted disease. See Sherine E. Gabriel et al., Risk of Connective-
Tissue Diseases and Other Disorders After Breast Implantation, 330 NEW ENG. J. MED. 1697, 1698, 1702
(1994) [hereinafter Mayo Clinic Study].
2. The examples of television reports are so numerous as to make an exhaustive list impractical. For a
report that casts doubt on safety problems with silicone implants in a manner that is neither sensational nor one-
sided, see The MacNeil Lehrer NewsHour (PBS television broadcast, Sept. 13, 1995).
3. See Gina Kolata, New Study Finds No Link Between Implants and Illness, N.Y. TIMES, June 22,
1995, at A18; see also Joan Beck, Hidden Agenda on Breast Implants, CIn. TIB., Feb. 29, 1996, at 23. Beck
asserts that cause (breast implants) and effect (disease) have not been scientifically established. See id. She
characterizes the arguments advanced to support a causal link as nothing more than a "folk tale," no more
plausible than the following story:
When my son was 5 years old, he often played with a little boy who lived across the street.
Whenever Roger got a small cut, his mother would gently lay the flat blade of a table knife on the
wound and hold it in place for a few minutes. I asked her why. "It makes the cut heal," she said. "It
always does."
Id.
4. See MARCIA ANGELL, SCIENCE ON TRIAL: THE CLASH OF MEDICAL EVIDENCE AND THE LAW IN THE
BREAST IMPLANT CASE (1996). Dr. Angell is the executive editor of the New England Journal of Medicine.
See id at 9.
5. See id. at 102-10. Occasionally, the media presents an opposing view. See, e.g., John E. Swanson,
Exposing a Corporate Cover-up, Cmn. TRIB., Apr. 15, 1997, at 15.
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that the earlier litigation documenting the dangers of silicone6 and the misdeeds
of surgeons,7 as well as exposing greedy and fraudulent behavior of corporations
such as Dow Coming,8 was apparently either in error or was itself a fraud
perpetrated upon the public by greedy, profit-seeking lawyers and physicians,
and by the media, hungry for the latest sensational story.9 Some of this literature
6. See Alan A. Bridges & Frank B. Vasey, Silicone Breast Implants: History, Safety, and Potential
Complications, 153 ARCHIVES OF IN'rNEitAL MED. 2638, 2639-43 (1993); Judy Foreman, Women & Silicone:
A History of Risk, BOSTON GLOBE, Jan. 19, 1992, at 1; Tamar Lewin, As Silicone Issue Grows, Women Take
Agony andAnger to Court, N.Y TIMES, Jan. 19, 1992, at 1.
7. One of the more dramatic claims of medical ineptitude involves a plastic surgeon who, in September
of 1977 after surgically inserting silicone gel implants into a patient's breasts, "intentionally slit the envelope to
allow the gel to escape" into the patient's breast tissue. Henderson v. Heyer-Schulte Corp., 600 S.W.2d 844,
846 (Tex. Civ. App. 1980). Although this surgical technique was not a "recognized or accepted" method for
breast augmentation at the time of the surgery, the jury found that the doctor had not committed malpractice.
Id. The fact that the Food and Drug Administration banned direct injections of liquid silicone in 1963 makes
the verdict in this case especially troubling. See Michele Simon, The Silicone Gel Breast Implant Controversy:
The Science Surrounding the Regulation and Litigation, 17 J. PRODUCTS & TOxICS LIABILITY 141, 143 n. 13
(1995). For a discussion of this case and others, see Stephen Lichtenstein, A Discussion of the Silicone Gel-
Filled Breast Implant Controversy, 12 REV. LrnG. 205, 214 (1992). Another alarming medical charge involved
a woman who had breast implant surgery after undergoing a double subcutaneous mastectomy for fibrocystic
disease. See Weinberg v. Bess, 638 N.E.2d 841, 843 (Ind. Ct. App. 1994). The plaintiff alleged that after
instructing the plastic surgeon to use saline implants, he instead inserted silicone gel implants into her breasts,
and that on several occasions after the surgery misrepresented her implants as saline. See id The court found
that the plaintiff's claim of malpractice was barred by the applicable statute of limitations. See id. at 844.
8. Dow Coming's allegedly fraudulent behavior was summarized in Hopkins v. Dow Coming Corp., 33
F.3d 1116, 1119 (9th Cir. 1994). The federal appellate court upheld the jury's finding of fraud based upon the
following evidence:
The evidence presented at trial indicated that Dow rushed development of the silicone gel
implants, failed to adequately test the implants, and ignored knowledge of adverse health
consequences associated with the implants. Plaintiff presented evidence that Dow created a
Mammary Task Force charged with getting the new gel implant to market in less than five months.
Even after a task force member presented his concerns about "a possible gel bleed situation" Dow
ignored proposed design modifications that would reduce the likelihood of leakage. The record
indicates that Dow instructed salesmen to wash the implants with "soap and water" in the nearest
restroom, and to "dry with hand towels as the implants become oily after being handled and [bleed]
on the velvet in the showcase."
The evidence further indicated that in addition to the evidence of silicone leakage, Dow
implants experienced a high rate of rupture. Despite proposals by one task force member to
implement a "multiple dip" method as a means of ensuring greater uniformity in the envelope, and
thereby less likelihood of rupture, Dow adopted the single dip method because it was "easier" and
"cheaper." After an incident in which two of the new gel implants "broke during augmentation
surgery for the TV taped demonstrations," Thomas Talcott, a Dow engineer, inquired of key Dow
employees, "When will we learn at Dow Coming that making a product 'just good enough' almost
always leads to products that are 'not quite good enough?'
There was also evidence that no research concerning the long-term health effects had been
conducted. The longest study to address possible adverse health effects of the implants took place
over only 80 days and revealed evidence of inflammatory immune response caused by the gel. Dow
continued to market these implants until 1987, without the benefit of a lifetime study to demonstrate
the safety of its product.
Other evidence at trial indicated that Dow had knowledge of the harmful effects of silicone on
the human body. Dow obtained results of a study in which four dogs received silicone gel implants
that resembled the implants that Dow was then marketing. The results demonstrated that after six
months, the implants appeared to be functioning properly, but that after two years, inflammation
surrounding the implants demonstrated the existence of an immune reaction. Dow did not publicly
release the results of this research for several years, and when it did ultimately release the results,
Dow omitted the negative findings and implied that the implants were safe.
Id
9. See ANGoELL, supra note 4, at 133-76.
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paints a picture of breast implant recipients as gullible, unwitting participants in
this fraud, while other reports describe implant recipients as extortionists looking
to exploit the deep pockets of manufacturers and surgeons. I0 Dr. Marcia Angell,
who offers the single most comprehensive defense of breast implant safety,
focuses upon a different concern:
The anti-science, anti-medicine strain in the feminist movement finds
expression in the breast implant controversy. Many women see the
controversy as a woman's issue in a political context, as well as a
biological one. Some female plaintiffs' attorneys make much of the fact
that they are women championing other women in a man's world. The
epidemiologic studies that fail to find a connection between breast
implants and disease are met with cynicism. To many feminists, the
scientific studies seem irrelevant and distracting in the context of a
perceived assault on women-first in subjecting them to implants, then
in failing to respond promptly to the hazard. After all, implants are
unnatural substances put in the body, and many women who have
implants get sick. When scientific data are put up against their own
"ways of knowing," some women ignore the science. Add to this anti-
science bias the view of many women that breast implants are a
manifestation of a discredited, masculine attitude that judges women
primarily by their looks, and it is no wonder that some feminists believe
that breast implants cause disease. They want to believe it."
All of this recently disseminated literature touting the safety of breast
implants has sent an important message to breast implant recipients-that the
public will no longer believe, or even take seriously, their complaints about the
negative impact that their implants have had on their health and on their lives.
Yet these observations in the form of near definitive conclusions overstate the
importance of the recently released studies to a number of the medical questions
raised in breast implant litigation and, in particular, the Revised Breast Implant
Settlement Program, 12 while simultaneously obscuring and glossing over the
10. See Note, Breast Implants: Choices Women Thought They Made, 11 N.YL. SCH. J. HUM. RTs. 163,
201 & n.214 (1993) (arguing that plastic surgeons and manufacturers are engaged in a large-scale, joint
"lobbying effort to convince both the public and the government that the health concerns surrounding silicone
implants are a creation of hysterical women and the plaintiff's trial bar"). Some proponents of breast implants
do not agree entirely with either perspective:
Women with breast implants are just as diverse as any other large population, and there is no reason
to believe that they are all the same-either in their health or in their character. But it can be very
difficult to distinguish the ill from the worried well and from the opportunists.
ANGELL, supra note 4, at 153.
11. ANGELL, supra note 4, at 182-83.
12. The Revised Breast Implant Settlement Program, which was officially approved on December 22,
1995 by Judge Sam C. Pointer, includes the following implant manufacturers: Bristol-Myers Squibb Company,
Baxter Intemational, Incorporated, Minnesota Mining and Manufacturing (3M), McGhan Medical Corporation,
and Union Carbide. In re Silicone Gel Breast Implant Prod. Liab. Litig., 887 F Supp. 1447 (N.D. Ala. 1995).
This settlement arose after the original, global class action settlement, In r Silicone Gel Breast Implant Prod.
1997]
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equally complicated legal and social issues involving breast implants. What is
most troubling, however, is the fact that not so very long ago many of these same
newspapers and television programs addressed the issues in an equally simple,
all-or-nothing manner: breast implants were dangerous, defective products; the
manufacturers and surgeons were culpable; and breast implant recipients were
tragic victims. 13
Indeed, even with the benefit of the recently released medical studies, we still
know very little about the long-term effects of breast implants on women's
bodies. This fact should not be surprising since no lifetime studies addressing the
safety of breast implants were conducted before their introduction in the early
1960s,14 and several studies are ongoing. 15 Even if every medical study presently
underway fails to establish a definitive link between breast implants and
particular diseases, the results will not compel the conclusion that breast
implants are medically safe devices. It may well be that a gap exists between our
current state of technology, which is advanced enough to produce this product,
and our understanding of the effect that this product has on the human body,
which itself is complex. 16
Thus, this kind of all-or-nothing approach to the study of silicone breast
implants is misguided because it is not conducive to further testing and to an
open dialogue over time that questions the assumptions we make about disease
and causation of disease. This narrow approach to the breast implant controversy
is also disturbing because it does not leave room for research that is necessary to
achieve a greater understanding of this women's health issue: it does not attempt
to formulate more advanced methods of monitoring implants for rupture and
leakage; it does not look for ways to accurately measure levels of silicone
Liab. Litig., No. CV92-P-10000-S, 1994 U.S. Dist. LEXIS 12521 (N.D. Ala. 1994), fell apart due to the large
number of claimants and Dow Coming's application for bankruptcy protection on May 15, 1995. In re Dow
Coming Corp., 211 B.R_ 545 (1997).
13. See Foreman, supra note 6; Lewin, supra note 6.
14. See Bridges & Vasey, supra note 6, at 2639 (stating that Dow implants were used in breast
augmentation surgery beginning in 1962). Some reports state that Dow began to market the first silicone gel
breast implants in 1963. See Stephen H. Osborn & Abby L. Hyman, Damage to Breast Implants From
Trauma, 44 FICC Q. 417, 417 (1994). There is no dispute, however, that long-term premarket studies were
not conducted. See Hopkins v. Dow Coming Corp., 33 F.3d 1116, 1119 (9"h Cir. 1994). In fact, Dow did not
begin to plan such a safety study until 1989. See Douglas R. Shanklin, Evidence for Immunological Disorders
Due to Silicone, 4 No. 2 MED. LEGAL ASPECTS BREAST IMPLANTS 5, 5 (1996).
15. One study currently underway is being conducted by the National Cancer Institute and is entirely
funded by the federal government. See Janet Van Winkle, Government Funds Implant Study, But There Are
Some Pitfalls, 3 No. 11 MED. LEGAL ASPECTS BREAST IMPLANTS 4, 4 (1995). "More than 20,000 women will
be included in the study, with approximately 12,000 breast implant patients, limited to women who had plastic
surgery before 1989, with health effects assessed for an average of 10-15 years." Id
16. See Simon, supra note 7, at 160. The study of breast implants is also difficult because all of the
medical research is, of necessity, retrospective rather than prospective. See id. For a discussion of the limits of
the available scientific studies regarding breast implants, see Heidi Li Feldman, Science and Uncertainty in
Mass Exposure Litigation, 74 TEx. L. REV. 1, 23-25 (1995). The article is dated in the sense that it was
published before publication of several of the more recently released studies, but it discusses the limitations
generally of animal studies, human case studies, and epidemiological studies. See id. It is also important to note
that research may, as with breast implants, be a direct result of litigation and thus may develop "in parallel with
legal proceedings" or may also "lag behind them." SHEILA JASANOFF, SCIENCE AT THE BAR 50 (1995).
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migration throughout the body; and it fails to find new methods which, short of
an invasive surgical procedure, effectively predict the remaining life span of
implants.1
7
The goal of all medical research about breast implants should be to learn
more about their effect on women's bodies and to help those women who
currently have silicone implants stay healthy. Although medical research has not
yet established silicone implants as a cause of particular diseases, there is no
dispute that physical harm can and has been caused by such things as rupture,
silicone migration, and capsular contracture, to name just a few of the medical
complications. 18 Notwithstanding these serious side effects and complications,
people remain camped out on either side of the issue, intent on reading the
medical data to support the beliefs they held before the recent set of medical
testing ever began. 19 This dichotomous approach to the issue of silicone breast
implants has another negative effect: it necessarily results in the media
disseminating sound-bytes of misleading, premature conclusions.
The message that never reaches the public is that the majority of women with
breast implants, those who received their implants before approximately 1992,20
have become nonconsenting, de facto participants in these and, unfortunately, in
17. As such, we want to ensure that women with implants do not relive the feelings of alienation and
despair many Dalkon Shield recipients felt when they experienced medical complications:
For most of the years of illness, I lived in isolation with my problem. Doctors and the manufacturers
of birth control technology never acknowledged it or its source. Neither did my family, friends, or
colleagues. I continually met with such incomplete and uncompassionate responses as, "What's your
problem? You look fine to me!," "But your blood test is normal," and "What are you trying to teach
yourself by giving yourself this illness?" There are many sources for the ignorance and denial that
surround technology-induced disease, but the ultimate result of such frames of mind is that they
alienate sick people from the support and caring they deserve and they alienate all of us from
addressing the collective problem of technology's dangers.
CHELLIS GLENDINNING, WHEmN TECHNOLOGY WouNDS 16 (1990).
This is not to say that research in this area is entirely lacking. For a recent development in monitoring
implant integrity, see Leonard. T Yu et al., In Jitro Measurement of Silicone Bleed from Breast Implants, 97
PLASTIC AND RECONSTRONCTIVE SuRGERY 756 (1996). The focus in this area, however, could be significantly
stronger.
18. See infra notes 66-68, 73-75, 157, 174, 180 and accompanying text.
19. For example, Dr. Marcia Angell called for the FDA Commissioner, David Kessler, to lift the ban on
silicone implants in 1992, long before the release of any long-term medical studies including the Mayo Clinic
Study and the Nurses' Study. See Marcia Angell, Breast Implants-Protection or Paternalism? 326 NEW
ENG. J. MED. 1695, 1696 (1992) (editorial); Gina Kolata, Study Reports Small Risk If Any, From Breast
Implants, N.Y. TIMEs, Feb. 28, 1996, at A12.
20. This date is chosen because the FDA placed a moratorium on silicone gel breast implants in April of
1992. See Rebecca Weisman, Reforms in Medical Device Regulation: An Examination of the Silicone Gel
Breast Implant Debacle, 23 GOLDEN GATE U.L. REv. 973, 973-74 (1993). Access to silicone implants is
limited to those women who enroll in clinical studies and favors women who want the implants for
reconstructive rather than for purely cosmetic reasons. See id; see also Simon, supra note 7, at 149 & n.60;
Note, supra note 10, at 190-91 & nn. 149-51. It is likely, however, that many people learned about the potential
dangers associated with breast implants a few months earlier on November 8, 1991, when Connie Chung
delivered a television report on the topic. Face to Face with Connie Chung: Breast Implants: Risky Business
(CBS television broadcast, Nov. 8, 1991). In this report, Chung interviewed several women whose lives
became "a nightmare" after receiving silicone breast implants, as well as a physician who confessed that "We
have done a large-scale clinical experiment on an unproven, probably unsafe, medical device" involving two
million American women. Id.
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future safety studies.21 These women are living, breathing lifetime studies. In
their case, to focus exclusively or even primarily upon the current research and
safety data ignores the simple reality that these studies were not available when
they made their decisions to undergo breast implant surgery. Instead, an analysis
of their legal and medical situation should begin with what was known about
breast implants at the time that they underwent breast augmentation surgery,
what was not known, what the doctrine of informed consent means in our
medical and legal systems, and what does or should constitute compensable,
physical harm in our legal system.
In Part H of this article, in an attempt to provide a context for analysis of
these issues, I present a brief history of western beauty rituals and practices
unique to women. This history is followed by a discussion in Part UI of the
development of cosmetic surgery, which, because it is primarily performed upon
women for aesthetic purposes, can be seen as an almost inevitable technological
outgrowth of these earlier, more primitive beauty practices. There is, however,
one important difference with cosmetic surgery: the beauty "practice," or more
accurately, the physical change undertaken in the name of beauty, cannot be
performed without the intervention of a third party, the surgeon. Thus, the
development of surgery almost exclusively performed upon women is presented,
focusing first on the earliest gynecological surgical procedures and then on
cosmetic surgery.
After setting this stage, Part IV analyzes both existing law and the Revised
Breast Implant Settlement Program. Specifically, Part IV analyzes the legal
requirements for informed consent and the definitions of physical harm and
disease under the Revised Breast Implant Settlement Program. In this section, the
terms of the Revised Breast Implant Settlement Program are analyzed in
conjunction with the conduct of the manufacturers (and physicians) so as to shed
light on the complexities surrounding this medical device,22 made of silicone,
which, when broken down into silica, becomes toxic. 23 Experience with direct
21. It is true that federal regulations mandate that participation in either federal studies or those studies
subject to federal regulation be voluntary, 16 C.F.R. § 1028.116 (1996), and thus no woman with breast
implants can be required to participate in a study if she truly wishes to be excluded. The reality is that in order
to protect their future health, all women with silicone implants have very strong incentives to participate in any
and all studies. Additionally, women who are neither asked nor consent to participate in a controlled study are
in effect participating throughout the duration of their lives in a general study of breast implants because their
physicians will be monitoring their health. Unfortunately, involuntary participation is nothing new in the case of
silicone breast enhancement. During the 1960's, Dow Coming conducted experiments with liquid silicone on
women who had not actually consented. See Lichtenstein, supra note 7, at 208 & nn.20-21; Foreman, supra
note 6.
22. In addition to breast implants, silicone has a number "of medical applications, including intravenous
tubing, catheters, joint prostheses and penile" implants, Simon, supra note 7, at 142 & n.3. The FDA acquired
the authority to regulate breast implants in 1976 with the Medical Device Amendments to the Food and Drug
Cosmetic Act. 21 U.S.C. § 360(c) (1988). Breast implants, however, were not classified as a medical device
by the FDA until 1988. See STAFF OF HOUSE COMM. ON GOVERNMENT OPERATIONS, 102D CONG., 2D SESS.,
THE FDA's REGULATION OF SILICONE BREAST IMILANTS 4 (Comm. Print 1992).
23. See Bridges & Vasey, supra note 6, at 2640 (stating that "silicone is not inert" and that "silicone can
lead to marked tissue reactions"); Foreman, supra note 6.
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silicone injections of medical grade silicone into women's breasts, the breast
augmentation procedure utilized in this country prior to the introduction of the
silicone gel implant, has, in fact, demonstrated that this medical device is also a
toxic substance.24 It is thus this author's hope that the story of silicone breast
implants will provide important lessons about the need to assure individuals a
meaningful opportunity to make choices about medical care, particularly
elective, invasive medical procedures."
II. FEMININE BEAUTY RITuALS: A PAINFUL HISTORY
Breast augmentation is a drastic alteration of the body that has been
undertaken by as many as two million women in the United States. 26 It is
preceded by a virtually uninterrupted history of painful alteration of the female
body in Western culture." In fact, throughout recorded history, women have
engaged in various beauty practices, many of which, in addition to being painful,
were also dangerous.28 Of course, not all feminine beauty practices are or have
been harmful.29 For instance, Neanderthal women who painted themselves with
24. Liquid silicone injections allegedly produced "severe tissue reactions." See Foreman, supra note 6.
25. Efforts are under way to improve the quality and safety of breast implants, and it appears that a
replacement may have been found. The trilucent breast implant is available for women who qualify for a
clinical study. See Sally Ogle Davis, At Last-the Ideal Breast Implant?, COSMOPOLrrAN, Apr. 1997, at 140.
The implant is like the silicone gel implant in that the shell is made of silicone, but it is filled with medical
grade soybean oil, which is also used in intravenous feeding. See Prime ime Live: Shape of the Future (ABC
television broadcast, May 14, 1997). Critics argue, however, that this product was introduced after only a six
month study involving animals, and although soybean oil is not toxic if it is introduced into the body through a
rupture of the implant shell, we do not know what will happen over time if, for instance, the oil becomes rancid
and leaks into the woman's breast tissue and body. See id.
26. See Note, supra note 10, at 163; Face to Face, supra note 20. Other estimates place the number as
low as one million. See Gayle L. Troutwine, Beauty and the Beast, Breast Implants: A Beauty Fraud, TRIAL,
Aug. 1993, at 48, 49. FDA estimates support the latter, lower number. See Kerith Cohen, Note, Truth &
Beauty, Deception & Disfigurement: A Feminist Analysis of Breast Implant Litigation, I WM. & MARY J.
WOMEN & L. 149, 159-60 (1994). Although in rare instances men have undergone breast augmentation
surgery, for example transsexuals, the surgical procedure is overwhelmingly performed on women. See Sarah
Tankersley, Note, Reproductive Freedom: Abortion Rights of Incarcerated and Non-Incarcerated Women, 85
KY. L.J. 219, 226 (1997).
27. See SHARLENE HESSE-BIBER, AM I THIN ENOUGH YET? THE CULT OF THINNESS AND THE
COMMERCIALIZATION OF IDENTITY 20-26 (1996). For an example of a very painful, bizarre practice, in which at
least some women engaged in the name of beauty, see Eugenie Anne Gifford, "The Courage to Blaspheme":
Confronting Barriers to Resisting Female Genital Mutilation, 4 U.C.L.A. WOMEN's L.J. 329, 361-62 (1994)
(arguing that the clitoridectomy "briefly reached fad proportions" in this country and was viewed by some
women as a form of fashion).
28. See NANCY C. BAKER, THE BEAUTY TRAP 15 (1984). The author interviewed women from America,
Latin America, Europe and the Middle East and found that all of these women were preoccupied with physical
appearance and beauty. See id. at 8.
29. See Cohen, supra note 26, at 157 (describing such beauty products as eye shadow, nail polish, and
lipstick); BAKER, supra note 28, at 14. Although men have also spent time on their appearance, their rituals and
practices have not been as time consuming or as extreme. See id. at 18. "[W]hatever sartorial devices men
have put on to bolster their body image-codpieces, elevated shoes, padded shoulders, a boxy jacket-these
did not constrict or cause pain." SUSAN BROWNMILLER, FEMININITY 35 (1984).
Yale Journal of Law and Feminism
ocher3o and wore jewelry made of shells provide the earliest evidence of female
adornment.31
In Western culture, the identification of beauty predominantly with the
female gender can be traced to the Greeks, who ascribed different virtues to men
and women, with beauty as a feminine virtue indicative of good character.32 In
non-Westem cultures, both women and men believed deforming beauty rituals
were a distinctive badge of moral correctness and evidence of a position of
privilege and leisure within society.33 Although the focus of this discussion is on
Western practice, it is interesting that in the United States cosmetic surgery is an
accepted practice and Chinese foot-binding, as described below, is viewed as an
oppressive act of mutilation:
[T]he Chinese ... discovered that, by binding the feet of young girls, they
could create a foot deformity resulting in a natural sort of "high heel." As
the girl's foot grew, her toes became permanently twisted under the arch.
The pain females must have endured in the name of beauty during the
thousand years that foot-binding was customary in China can hardly be
imagined. Yet some must have felt that the price was not too high. For
the more petite her foot-the more tightly bound it was-the more
beautiful the Chinese woman was considered to be.34
What remained of a woman's foot after undergoing this painful process for
years was a deformed stub of approximately three to four inches. 3' Women were
unable to stand without support or to walk without the use of a cane or the
assistance of a servant or a man.36 Such women were romanticized, even
eroticized, within Chinese culture.37 Ironically, not only was this a practice
Chinese women endured, they were active participants as they imposed this
same ritual upon their young daughters.38 As will be seen in the discussion that
30. Ocher is a "mineral oxide of iron" that is either "yellow, brown, or red" in color. See THE AMERICAN
HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE 1251 (3 d ed. 1992).
31. See BAKER, supra note 28, at 14.
32. See Lois W. BANNER, AMERICAN BEAUTY 10 (1983). The word "beauty," which is of Latin
derivation, means good. See id. It was initially "applied only to women and children; later it was used ironically
to describe men." Id.
33. See BROWNMILLER, supra note 29, at 33.
34. BAKER, supra note 28, at 15.
35. See BROwNMILLER, supra note 29, at 33; HESSE-BBER, supra note 27, at 20-21.
36. See BAKER, supra note 28, at 15 (stating that this practice provided "an obvious reward for men" in
that "women with bound feet became virtual prisoners in the home, barely able to walk, much less run away
from their men"); BROWNMILLER, supra note 29, at 33-34 (characterizing this practice as the "violent
subjugation of women").
37. The lotus blossom, a revered flower in Chinese culture, became the metaphor for the woman's
deformed, useless foot. See BROWNMILLER, supra note 29, at 33. "Making love to the lotus foot, an elaborate
art of manipulation, postures and poses, was a dominant theme in Chinese pornography for eight hundred years
while the custom of footbinding flourished." Id. at 34.
38. See id. Brownmiller observed that foot-binding:
demanded the shared complicity of mother and daughter in the desperate work of beautification and
the passing on of compliant, submissive feminine values, for the anxious mother was the agent of
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follows, Western beauty practices were similarly thought to symbolize
aristocratic stature; women actively engaged in these rituals, they imposed them
on their daughters, and they believed them to be necessary components of
feminine sexual appeal. 39 Eastern and Western beauty rituals share important
facets of pain and disfigurement because many women believe that the natural
shape of their bodies, or some aspect of their bodies, is inadequate, even
defective.40 Yet our cultural bias blinds us from seeing Western beauty practices
in the same light that we see Eastern ritual-as torturous, mutilating, masochistic
acts.
One little known beauty aid utilized by women in the United States at the
end of the eighteenth century was ceruse, a type of make-up applied to the face
in order to produce the appearance of a fair complexion. 41 This substance was, in
fact, a toxic white paint that had a lead base.42 Even though there were reports
that women had damaged their skin by using this product and that, in some
instances, women had "suffered slow deaths," ceruse remained a popular beauty
tool.43 In the early nineteenth century, women also ingested "vinegar, chalk, or
even arsenic to obtain a delicate complexion."" During these periods, women's
hair styles were elaborate, taking hours to create and including hairpieces or
wigs. 45 They wore heavy, large skirts with equally heavy undergarments that
proved warm and inhibited movement.46
Another beauty device and probably the single most restrictive, painful part
of a woman's attire beginning in the sixteenth century and continuing through to
the turn of the twentieth century was the corset.47 It was originally made of
will who crushed her suffering daughter's foot as she calmed her rebellion by holding up the promise
of the dainty shoe, teaching her child at an early age that the feminine mission in life, at the cost of
tears and pain, was to alter her body and amend her ways in the supreme effort to attract and please
a man.
Id; see also HESSE-BBER, supra note 27, at 20 (describing the story of a girl whose mother started binding her
feet at age seven).
39. See BROWNMILLER, supra note 29, at 33-34.
40. See id. at 36-3 7. Brownmiller finds the homogenizing aspect of fashion and beauty troubling. She
writes, "nearly every civilization has sought to impose a uniform shape upon the female body, a feminine
aesthetic that usually denies solidity by rearranging, accentuating or drastically altering some portion of the
female anatomy or some natural expression of flesh." Id. at 33.
41. See BAKER, supra note 28, at 18.
42. See id.
43. See id.
44. BANNER, supra note 32, at 41. Arsenic ingestion can be traced to garbled scientific reports of an
Austrian biologist, Johann Frederick Blumenbach, who asserted that "European stock" could be traced to the
Caucasus (from which he coined the term "Caucasian"). Id. Circassian women who lived in the Caucasus were
alleged to have beautiful complexions, and during the early nineteenth century, it was rumored and reported
that these women ate arsenic to achieve their beautiful complexions. See id. In addition to oral ingestion,
doctors prescribed topical creams and lotions that contained arsenic to battle adolescent acne. See id. The
complexion of most men and women during this time in history was probably poor due to a diet high in fat. See
id. Additionally, the desire for a translucent, clear complexion may have been inspired by a glorification of
consumption, a disease that affected women disproportionately and was incurable. See id. at 51-52.
45. See BAKER, supra note 28, at 17-19.
46. See id.
47. See HESSE-BIBER, supra note 27, at 24-25. Not only was the purpose of wearing the corset to
produce a small waist, but one author asserts that "[wihether American women knew it or not, tightlacing was
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wood, whalebone, or metal until the advent of the iron corset in the late sixteenth
century.48 Catherine de Medici, Queen of France, is credited with introducing the
iron corset in accordance with her decree that the ideal waist measurement for a
woman of her time was thirteen inches.49 Throughout most of the seventeenth
century, the ideal waist measurement was thought to be no more than eighteen
inches.50 Both of these measurements were unrealistic aspirations for women and
were achieved at a high cost, including organ displacement, headaches, fainting,
and breathing problems.51 In the middle of the nineteenth century, many women
began using padding to accentuate their breasts and hips.52 Thus, fashion
demanded the impossible of women, voluptuous breasts and hips with a child-
like waist.
53
Once again, women imposed this ritual, which required the exertion of as
much as eighty pounds of pressure on the body and took as long as one-half hour
to accomplish each day, on their daughters. 54 The following letter illustrates a
young woman's indoctrination into this right of womanhood:
designed to increase the size of the bosom and hips by reducing the size of the waist and pushing excess flesh
upward and downward." BANNER, supra note 32, at 60.
48. See Baker, supra note 28, at 16.
49. See id. Queen Elizabeth I of England is also credited with popularizing the corset See
BROWNMILLER, supra note 29, at 35.
50. See BANNER, supra note 32, at 48. "Proper Victorians believed that a woman's frail body required
the support of a corset." Id.
51. See BAKER, supra note 28, at 19-20. "The clergy spoke from their pulpits against the contraptions,
noting that, when pregnant women laced themselves tightly in order to look socially respectable, abortions were
frequently the result." Id. at 20. Doctors and reformers during this period also believed that corsets "may have
been a primary cause of the uterine and spinal disorders wide-spread among nineteenth-century women."
BANNER, supra note 32, at 48. In rare instances, death resulted. See HESSE-BIBER, supra note 27, at 25. A
young woman, whose mother required that she wear a tightly-laced corset, died at the age of 20 because "her
ribs had grown into her liver" and "her entrails were much hurt by being crushed together with her stays." Id.
52. See BANNER, supra note 32, at 60-61. One such inflatable device, the "gay deceiver," was made of
rubber. Id. at 61.
53. During this time, "[m]any women embarked on what seems to be cross purposes: They went on
crash diets to gain weight while simultaneously strapping themselves into smaller and smaller waistlines."
BAKER, supra note 28, at 20. Some of these women are reported to have had ribs surgically removed. See id.
As the nineteenth century progressed, different fashion trends that were built around the corset emerged. See
BANNER, supra note 32, at 68-69. One such fashion of the late 1860's, the "S-shaped silhouette," involved an
extremely accentuated "bulging" hips and buttocks with a very narrow waist. Id. at 68.
54. See BROWNMILLER, supra note 29, at 36-37. It is not surprising that women accepted and
perpetuated this beauty ritual. They were surrounded by images reflecting an ideal body-type that mirrored the
look the corset providea. One art historian has noted that many famous artists throughout history have depicted
the nude female body not in its natural state, but instead in conformity with the illusion that the corset created.
See ANNE HOLLANDER, SEEING THROUGH CLOTHES 128-34 (1978).
At any time the unadorned self has more kinship with its own usual dressed aspect than it has with
any undressed human selves in other times and places, who have learned a different visual sense of
the clothed body. It can be shown that the rendering of the nude in art usually derives from the
current form in which the clothed figure is conceived.
Id at xiii.
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I was placed at the age of fifteen at a fashionable school in London, and
there it was the custom for the waists of the pupils to be reduced one inch
per month until they were what the lady principal considered small
enough. When I left school at seventeen, my waist measured only thirteen
inches, it having been formerly twenty-three inches in circumference.
Every morning one of the maids used to come to assist us to dress, and a
governess superintended to see that our corsets were drawn as tight as
possible. After the first few minutes every morning I felt no pain, and the
only ill effects apparently were occasional headaches and loss of appetite.
I should be glad if you will inform me if it is possible for girls to have a
waist of fashionable size and yet preserve their health. Very few of my
fellow-pupils appeared to suffer, except the pain caused by the extreme
tightness of the stays. In one case where the girl was stout and largely
built, two strong maids were obliged to use their utmost force to make
her waist the size ordered by the lady principal-viz., seventeen inches-
and though she fainted twice while the stays were being made to meet,
she wore them without seeming injury to her health, and before she left
school she had a waist measuring fourteen inches, yet she never suffered
a day's illness. 5
As always with beauty, fashion changed and, when corsets were no longer in
vogue, other painful, body-altering rituals emerged. In the 1920's, women with
large breasts bound them to create the illusion of small breasts. 56 As will be
discussed in the following section, shortly after this time, women began turning
to surgery for enhancement of their breasts.57 For the past twenty or more years,
the ideal female has gotten thinner while her breasts have gotten larger.58 A
recent study revealed that the dimensions of the average department store
mannequin would translate into a woman who would probably be too thin to
menstruate. 59 While fashions change, one factor remains constant: the ever-
changing fashion ideal is unattainable for the vast majority of women who,
55. BAKER, supra note 28, at 19. This letter was printed in the May 1867 issue of English Women's
Magazine. See id.
56. See BROWNMILLER, supra note 29, at 39.
57. See Lichtenstein, supra note 7, at 207-08.
58. See BAKER, supra note 28, at 25; see also HESSE-BIBER, supra note 27, at 3-6 (dating the trend
toward an unnaturally thin beauty ideal to the 1960's).
59. See Cohen, supra note 26, at 158 & n.79. The author notes that while the ideal woman has become
"taller and thinner," the average American woman has gotten heavier. Id. at 158. Recent studies of both men
and women support this conclusion for the population as a whole. Hesse-Biber notes that "[in 1983, 58% of
the adult population age 25 years and older weighed more than recommended for their height and frame size.
In 1987, the figure rose slightly to 59%, climbing to 63% in 1992." HESsE-BBER, supra note 27, at 37. In
1994, the obesity rate among American adults was reported to have increased from 25% to 33%. See id.
Anorexia nervosa and bulimia, although seemingly modem afflictions, are not unique in the sense that frail, thin
figures have been prized in American history. During much of the nineteenth century, a frail soma-type was the
model for beauty. See BANNER, supra note 32, at 45-57. Many physicians from this era believed that the female
diet should consist of only light fare, including "toast, tea, a bit of chicken or bouillon." Id. at 50. Cases of
anorexia increased again in the 1920's, during the "Flapper Era." See HESSE-BIBER, supra note 27, at 27.
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undeterred, hurt their bodies to achieve beauty.60 When viewed in light of this
history, the effects of foot-binding are only different from the restrictions
imposed by the corset in terms of the degree of immobilization of the body.
Unlike the foot-binding ritual, the corset did not directly impede walking, but
instead made other routine acts of breathing and sitting difficult.
61
Situated in this historical context, breast augmentation surgery appears to be
a natural technological evolution in feminine beauty practices. 62 We accept it as
part of our culture because women voluntarily engage in the practice and also
because society at large is probably unaware of the level of pain, damage, and
even deformity that can result from a "successful" augmentation surgery. Breast
augmentation surgery takes from just under one hour to two hours to complete
and usually results in a two or three inch scar beneath each breast.63 Although
many women immediately return home after the procedure, many also
experience pain for days and even for a week or more following surgery.64 The
surgery is considered minor, but women are advised by their physicians to refrain
from exercise and other physical exertion for a minimum of three weeks after a
routine breast augmentation procedure so that their bodies can heal; they suffer
from swelling and bruising on and near their breasts and over their rib cage.65
Thirty to fifty percent of all "successful" operations will result in side
effects.66 The most common of the adverse effects include partial or total loss of
nipple sensation and numbing of the breasts due to nerve damage, painful
hardening of the breasts, and breasts that are not symmetrical.67 A somewhat less
common but more deforming and painful side effect occurs when tissue
surrounding the implanted breast "becomes doorknob-shaped, rock hard, and
60. See BAKER, supra note 28, at 14-26; see also Gifford, supra note 27, at 362-63 (discussing this
issue in the specific context of breast augmentation surgery); FRANK B. VASEY & JOSH FELDSTEIN, THE
SLICONE BREAST IMPLANT CONTROVERSY: WHAT WOMEN NEED TO KNOW 5 (1993) (citing statistics that show
that the average woman is 9% shorter and 16% heavier than the female models she sees).
61. See BROWNMILLER, supra note 29 at 36.
62. See VASEY & FELDSTEIN, supra note 60, at 5 (comparing the corset to the "high-tech means"
cosmetic surgery now provides for beautification).
63. See id. at 127-28. This type of incision is the most common and is known as an inframammary
incision. See id There are two other options, the axillary incision (the armpit) and the periareolar incision (the
nipple). See id.
64. See id. at 125-27 (discussing possible side effects of surgery and stating that "[niormal activities can
usually be resumed gradually after one week's time, with more strenuous activities avoided for approximately
three weeks."). For a discussion of one woman's experience with breast augmentation, see JOHN A. BYRNE,
INFORMED CONSENT 69-70 (1996).
65. See VASEY & FELDSTEIN, supra note 60, at 125-27.
The recovering patient will need to avoid reaching up or out for about three days; she should also
sleep on her back with her head elevated for about seven days. Normal activities can usually be
resumed gradually after one week's time, with more strenuous activities avoided for approximately
three weeks post-op.
Id. at 127; see also KAREN J. CARLSON et al., THE HARVARD GuiDE TO WOMEN'S HEALTH 108-09 (1996).
66. See KATHY DAVIS, RESHAPING THE FEMALE BODY: THE DLEMMA OF COSMETIC SURGERY 27
(1995). The truth is that we do not know what percentage of women have complications after breast
augmentation surgery. See ANGELL, supra note 4, at 40-41. The reason for our lack of knowledge may be due
to physician self-interest: the physicians may not keep thorough records or report these problems to the FDA.
67. See DAVIS, supra note 66, at 27-28.
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painful. 68 When this side effect known as capsular contracture occurred in the
past, a closed capsulotomy (external pressure applied to the breast by the
surgeon)69 was performed to release the hardened tissue. Now, surgical removal
of the implants is the recommended procedure, and in the worst cases, the
hardened implants must "be literally chiseled from the patient's chest wall."7 °
In such instances, the implant removal process can be a harrowing
experience, especially when the surgeon has not prepared the woman in advance
for the physical discomfort and pain likely to accompany the removal surgery.
One woman who had her breast implants removed while under local anesthesia
(she was awake during the surgery) experienced the following:
During the explantation, the surgeon cut through the original incisions to
retrieve Ellen's implants, which had been inserted submuscularly. "He
had to cut through all that muscle to get them out," she said. "And they
didn't pop right out. It was a tug-of-war game. He tugged and tugged and
pulled to get them out. At times, he was lifting me off the table. I could
feel my skin burning. I could feel him cutting. I could smell it, hear it
sizzling, and I told him I could feel that. He didn't . . . he didn't
acknowledge it."
71
68. Id. Some estimates are that this side effect occurs in up to 35% of breast augmentation procedures.
See id. Others estimate that the occurrence rate is as high as 50%. See ANGELL, supra note 4, at 41. One
manufacturer, McGhan Medical Corporation, estimated the rate of capsular contracture to be as high as 74%.
See VASEY & FELDSTEIN, supra note 60, at 96. The estimates of implant rupture also vary. See id. In 1992, one
plastic surgeon reported a four to six percent rupture rate, while another plastic surgeon noted that implants
which were removed that were more than ten years old were "almost always" ruptured. Id; see also Donna L.
de Camara et al., Rupture andAging of Silicone Gel Breast Implants, 91 PLASTIC RECoNSTRUCTVE SURGERY
828, 829 (1993).
69. See VASEY & FELDSTEIN, supra note 60, at 102. This procedure is performed without the aid of
anesthesia and has been described by women who have undergone it as excruciatingly painful. See id. Due to
the high rate of implant rupture from this procedure, some manufacturers now provide package inserts that
warn against this procedure. See ANGELL, supra note 4, at 42. It is not known how many surgeons still practice
this painful and dangerous technique.
70. DAVIS, supra note 66, at 28, see also CARLSON, supra note 65, at 110 (stating that "[slqueezing the
breast to rupture the capsule is not recommended, since this can actually damage the implant.") Although it is
not recommended by the manufacturers, closed capsulotomy is described as a viable procedure in plastic
surgery textbooks, which were published as recently as 1995. A detailed discussion of the procedure taken
from one textbook follows:
The technique of compression around the prosthesis [breast implant], building a force great enough
to cause a fracture in the capsular wall, has proved highly successful in a majority of patients. The
technique should be performed with the discomfort of the patient in mind, and the patient should be
aware that damage to the prosthesis can result in this procedure .... The procedure is simple to
perform in the office and usually causes only slight discomfort to the patient. Sedation or other
means of diminishing pain response should not be administered. The patient's discomfort should be
the surgeon's guide .... Hematoma that requires surgical intervention can occur from the closed
capsulotomy. Incomplete rupture of the capsule wall can cause bizarre shapes caused by hemiation
of the prosthesis through the weakened defect in the capsule wall. This condition could require later
surgical correction.
BERNARD M. BARRETT, JR., PATIENT CARE IN PLASTIC SURGERY 411-13 (2d ed. 1995).
71. VASEY & FELDSTEIN, supra note 60, at 47. Typically, implant removal is made difficult due to the
calcifications that develop around ruptured or older implants. See infra notes 273-75 and accompanying text.
Explantation procedures performed upon younger implants are generally not as traumatic because these
implants are less likely to be ruptured. See de Camara, supra note 68, at 828-29; see also VASEY &
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The fully numb or hardened misshapen breast, and the painful implant
removal process begin to resemble the pain and mutilation caused by the corset
or even the foot-binding practice.72 It is true that a woman who suffers adverse
consequences from breast implant surgery remains able to walk, sit, and breath;
however, for some women, a basic function, breast feeding, is either lost or
impaired.73 This consequence has been virtually ignored by the manufacturers.
In fact, Dow Coming performed only one study on four women who were breast
feeding their babies by comparing the milk samples of the two who had implants
with the two who did not.74 Unfortunately, women with implants have been
assured that it is safe for them to breast feed, despite the lack of supporting
evidence.75
Moreover, eighty percent of the time breast augmentation surgery is
performed for cosmetic reasons.76 If severe deformity, pain, and disfigurement
occur, the result is completely at odds with the initial goal of aesthetic
"improvement." Any analysis of breast augmentation must also take into account
the unique nature of breasts, their visibility and symbol of sexual maturity,
femininity, and sexual appeal.77 It is not a great inferential leap to conclude that
if women were informed that one of every three implant operations would likely
result in these consequences, many more would choose not to undergo this
FELDSTEIN, supra note 60, at 129 (discussing explantation procedures for implants that are not ruptured and
noting that "[s]urgically related complications should in most cases be minor"). These procedures are,
however, invasive surgical procedures and the pain and discomfort they cause should not be minimized. See id.
at 129-30.
72. One author has argued that plastic surgery is a "barbaric" form of self-mutilation similar to foot-
binding practices, dowry deaths, and even clitoridectomies. Ruth Rosen, Perspective on Women I Health:
Draw the Line at the Knife, L.A. TivES, Nov. 17, 1991, at M5; see also Karen Engle, Female Subjects of
Public International Law: Human Rights and the Exotic Other Female, 26 NEw ENG. L. REV. 1509, 1511
(1992). Another writer, in the context of discussing cosmetic surgery, has commented that "the nineteenth
century corset may have been unhealthy... but the twentieth century has produced an even more constraining
corset-the woman's own skin." DAVIS, supra note 66, at 41. This latter author argues that "the amount of
damage inflicted in the course of beautifying the body tends to be directly related to the development of
technology." Id.
73. See VASEY & FELDSTEIN, supra note 60, at 40-41. FDA mandated warnings for patients state: "The
surgical implantation of the device [breast implant] may interfere with a woman's ability to nurse her baby...
Although this is a known risk, the extent of the risk is unknown." Troutwine, supra note 26, at 50; see also
Note, supra note 10, at 167 & n.23 (discussing claims for injury made by children who were breast fed). It is
unknown whether silicone, which bleeds through the implant in all cases, can get into breast milk and be
ingested by babies. See Terri D. Keville, The Invisible Woman: Gender Bias in Medical Research, 15
WOMEN'S RTS. L. REP. 123, 131 n.97 (1993-94).
74. See id
75. See id. However, a study performed in 1994 "suggests that breast-fed infants of mothers with
implants may develop diseases of the digestive tract with permanent effects." Id (citing Jeremiah J. Levine &
Norman T. Ilowite, Sclerodermalike Esophageal Disease in Children Breast-Fed by Mothers with Silicone
Implants, 271 J. AM. MED. ASS'N 213 (1994)).
76. See Note, supra note 10, at 163. Between 1962-91, 80% of the breast augmentation surgeries
performed were cosmetic. See id.
77. See generally DAPHNA AYALAH & ISAAC J. WEINSTOCK, BREASTS: WoMEN SPEAK ABOUT THEIR
BREASTS AND THEIR LIVES (1979) (discussing women's ambivalence about their breasts).
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elective surgical procedure for the simple reason that there is a real risk that their
breasts will look worse rather than better after the surgery.
78
A critical difference that separates silicone breast implants from the other
more primitive beauty rituals is the addition of the surgeon in the beautification
process and the relative permanence of the alteration to the body.79 Thus,
women's relationship with their physicians necessarily complicates any
investigation of this issue, regardless of the investigative perspective.
Il. WOMEN AND SURGERY
Cosmetic or plastic surgery,80 which has its roots in reconstructive surgery,8'
is nearly exclusively performed on women: physicians estimate that ninety to
ninety-five percent of all such patients are women.82 This is not to say that men
never undertake cosmetic surgery, just that they do so in significantly smaller
numbers.8 3 The trend is changing, with an increase in the total number of
cosmetic surgical procedures performed on men; however, the number of women
78. See Naomi Wolf, Keep Them Implanted and Ignorant, in MINDING THE BODY: WOMEN WRITERS ON
BODY AND SOUL 187, 188 (Patricia Foster ed., 1994) (arguing that "even if a woman does full-time funded
research for six months, she won't find facts she needs to make a genuinely informed choice"). But see DAVIS,
supra note 66, at 142-47 (describing women who after experiencing many of the above mentioned side-effects
stated that they did not regret their decision to have breast augmentation surgery). This anecdotal evidence does
not resolve the issue of informed consent. Women may express satisfaction with breast augmentation surgery in
the face of serious side-effects due to cognitive dissonance. See Solveig Beale, et al., Augmentation
Mammoplasty: The Surgical and Psychological Effects of the Operation and Prediction of the Result, 13
ANN. PLAST. SUR6. 279, 290, (Oct. 1984). They may have made a choice to have breast implants against the
advice of family members or other important people in their lives, and they may not be able to admit
dissatisfaction either to themselves or to others. See id at 290.
79. Although many surgical procedures, face lifts and breast implant surgery, are not expected to last a
lifetime, they are longer lasting than was the illusion created by the corset. Corsets actually had an opposite
effect on the appearance of women's bodies in their natural state. See BROWNMILLER, supra note 29, at 36. A
woman's muscles became "miserably atrophied from disuse and binding;" thus, the moment the corset was
removed, a woman's waistline was larger and less defined than if she had never wom a corset. Id It is
estimated that a face lift should be repeated in five years while breast implants should be replaced within 15
years. See DAVIS, supra note 66, at 24-28.
80. The phrase "plastic surgery" comes from the Greek word "plassein," which is a word associated
with art and sculpture. JOACHIM GABKA & EKKHAD VAUBEL, PLASTIC SURGERY PAST AND PRESENT, ORIGIN
AND HISTORY OF MODERN LINES OF INCISION vii (1983). For purposes of this article, the terms "cosmetic" and
"plastic" are used interchangeably to refer to the branch of this surgical specialty that is concerned with
alteration of the body for aesthetic reasons.
81. Reconstructive surgery is generally "for restoring physical dysfunction or for minimizing
disfigurement due to disease, congenital deformity, or accident." DAVIS, supra note 66, at 16. The first reports
of reconstructive plastic surgery can be traced to 1000 B.C. in India when, after an individual was punished by
having his nose cut off or an adulterous wife was punished by her husband who bit her nose off, the nose was
surgically reattached. See id. at 14.
82. One author cites the figure as approximately 90%, see id. at 21, while another reports that the
American Society of Plastic and Reconstructive Surgeons places the figure at 94 %. See HESSE-BmER, supra
note 27, at 53. Until the middle of the twentieth century, however, cosmetic surgery was not a female province.
Instead, its initial development in the United States, England, France, Germany, and Italy as a surgical specialty
with an emphasis on reconstruction was spurred by the many casualties from war, particularly the Crimean
War and the First and Second World War. See DAVIS, supra note 66, at 16; GABKA & VAUBEL, supra note 80,
at 3-4.
83. See HESSE-BIBER, supra note 27, at 103-05.
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who undergo some form of cosmetic surgery is still seven times greater than the
corresponding number of men.
84
The first recorded breast surgery, performed in 1560, involved neither
reconstruction nor cosmetic alteration, but rather amputation to relieve extreme
discomfort caused by excessive weight and proportion."5 The amputation, or for
that matter, any surgical procedure, was performed as a last resort for the simple
reason that most invasive procedures proved fatal until after the introduction of
general antiseptic agents in 1870.86 In the late nineteenth century, breast
reduction procedures became common.8 7 As for breast augmentation, the first
recorded procedure was performed in Germany in'1895.88 The surgeon removed
fat from a non-cancerous tumor located on a woman's back and surgically
inserted it into her breasts.89 Following this and other unsuccessful attempts (the
fat was absorbed by the body), surgeons during the 1930's and 1940's
experimented with various foreign agents including paraffin wax, petroleum
jelly, bees wax, vegetable oils, and even sponges and glass balls.90 The results
were poor, producing infection, scar tissue, and lumps around the implanted
substance.9 1
Direct liquid silicone injections into breasts followed. This was a technique
developed in post-World War II Japan for prostitutes who wished to satisfy the
American or Western male preference for large breasts and, subsequently, it was
84. See id. at 105. One doctor expressed his views regarding the increase in male consumption of plastic
surgery, which continues to be outstripped by the female demand for cosmetic surgery:
We still don't view men and women as the same, and until our aesthetic demands on men equal the
ones that continue to be placed on women, we will still see more women responding to those
pressures through cosmetic surgery. However, I do see an increase in men having cosmetic surgery,
and the most common reason that I'm encountering is economic. It's the male who is rising up the
economic ladder and usually achieves his greatest economic success in his fifties and sixties. Now he
needs a physical appearance that is consistent with his power and his place in society.
Id.
85. See GABKA & VAUBEL, supra note 80, at 95. The reason given for the amputation was that "both
breasts had assumed such great proportions that she [a maidservant] could not support them, neither standing
up nor being seated." Id.
86. Dr. Joseph L. Lister is credited with discovering the need for such antiseptic agents such as "alcohol,
turpentine, carbolic acid" and other similar agents to prevent infection. Id. at 146. Prior to the introduction of
antisepsis, amputations of the breast were reserved for situations in which tumors had grown to enormous
proportions. See id. at 73. The procedure was performed by a barber surgeon who would pull the breast out
and away from the body and then the breast would be quickly "cut off altogether close to the thorax, using a
large amputation knife." Id. at 74. The procedure had to be performed quickly because anesthesia had not yet
been developed. See id. at 92-93. The survival rate was as low as four out of every 60 surgical patients
surviving for more than two years. See id. at 93. As one surgeon explained in 1773: "When the disease cannot
be repelled by any other means, we have to turn to the operation as the best palliative means; dying of a slow
fever is, after all, a gentler form of death than dying of the most hideous putrescence of cancer." Id.
87. See DAVIS, supra note 66, at 25.
88. See ANGELL, supra note 4, at 35.
89. See id; see also Lichtenstein, supra note 7, at 207.
90. See id at 207-08; see ANGELL, supra note 4, at 35.
91. See DAVIS, supra note 66, at 25 (stating that these substances "often hardened, protruded or caused
fluid to accumulate in the breasts, which then had to be drained"); see also ANGELL, supra note 4, at 38;
Lichtenstein, supra note 7, at 208.
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imported into this country.92 The silicone often migrated to the soft tissue
surrounding the breasts, the armpits, and to both regional and distant
lymphnodes.93 With the migration of the silicone came disfiguring lumps, but
this was not all that happened; some women's breasts became infected with
"gangrenous sores sometimes develop[ing] on the overlying skin or nipple., 94 As
many as 50,000 American women received silicone injections before the practice
was made illegal in this country.95 In 1962, Dow Coming, apparently undeterred
by the adverse effects of liquid silicone on the female breast and body, decided to
encapsulate silicone gel in "a rubbery silicone envelope" for implantation into
women's breasts.96
From 1962 or 1963 until 1992, when the FDA drastically curtailed the
availability of silicone breast implants for cosmetic purposes, Dow Coming and
other manufacturers successfully marketed breast implants.97 Even in the face of
the FDA moratorium and continuing restriction, breast implant surgery remains
one of the most commonly performed cosmetic procedures, ranking second or
third.98 Not only is cosmetic surgery a medical specialty, it is also a big business
in this country, generating five billion dollars in revenues annually, and this
figure is increasing every year by ten percent.99 The average annual income of a
92. See id. at 35-36. This type of silicone was not medical grade, but instead was "industrial strength
transformer coolant stolen from barrels on the docks of Japanese cities." Foreman, supra note 6, at 1. This
form of liquid silicone was the "forerunner of'silly putty. " Lichtenstein, supra note 7, at 208.
93. See Foreman, supra note 6, at 1. Because this silicone migrated, chemicals were added to cause the
body to react by forming scar tissue around the silicone product and thereby keep it inert. See id. Some medical
professionals assert that the reason for the adverse consequences was that the silicone was not pure, medical
grade, and the adulteration of the silicone was responsible for the harm to the women in both Japan and in this
country. See ANGELL, supra note 4, at 36-38. Other physicians agree that contaminated silicone was harmful;
however, they point to studies of medical grade silicone that was directly injected into body tissue and that had
similar adverse consequences. See Bridges & Vasey, supra note 6, at 2640. This latter group of physicians
state that "[t]he mechanism of regional dissemination of silicone is unknown; however, uptake by inflammatory
cells with migration to the reticuloendothelial system by way of the lymph channels or bloodstream is
suspected." Id.
94. ANGELL, supra note 4, at 38.
95. See Foreman, supra note 6, at 1. This figure included approximately 10,000 showgirls and
waitresses in Nevada. See id; see also Lichtenstein, supra note 7, at 208. In 1963, the FDA banned the use of
liquid silicone injections. In 1975, the Nevada legislature followed suit. See Simon, supra, note 7, at 143 &
n.13.
96. ANGELL, supra note 4, at 39. This figure is disputed; some reports state that the date of the first
implant by Dow Coming was 1963. See supra note 14 and accompanying text.
97. See ANGELL, supra note 4, at 34, 38-44.
98. See DAVIS, supra note 66, at 25 (stating that breast augmentation ranks second only to liposuction).
But see ANGELL, supra note 4, at 34 (asserting that in 1994 breast augmentation surgery ranked third behind
liposuction and eyelid surgery). In the same year, breast explantation (removal) surgery ranked fifth. See id
Since the availability of silicone breast implants for cosmetic surgery has been curtailed, the vast majority of
these women are having saline-filled implants placed in their bodies. See id These implants have historically
had a higher rupture rate, and since they are filled with fluid, a rupture results in immediate deflation of the
implant. See id. at 44. Due to their consistency, they are also thought to be less natural looking. See id. at 43-
44.
99. See HESSE-BIBER, supra note 27, at 51. The amount of money spent on breast augmentation during
its peak years (1979-92) would amount to $ 300 million to $ 450 million in present dollar values. See ANGELL,
supra note 4, at 34; see also DAVIS, supra note 66, at 20.
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plastic surgeon is nearly double that of pediatricians, internists, and general
practitioners. 100
Although cosmetic surgery patients are overwhelmingly female, cosmetic
surgeons are predominately male. 1 1 The most recent statistics set the percentage
of male plastic surgeons at approximately ninety-three percent. 10 2 Women are
represented at drastically lower rates in all surgical specialties, but their numbers
are markedly lower in the field of plastic surgery compared to numerous other
surgical specialties.
10 3
Strong parallels exist between cosmetic surgery and another field in which
women are the patients, men are the physicians, and an emphasis is placed upon
surgical intervention, a more aggressive form of treatment: gynecological
surgery.104 The history of this surgical specialty provides useful background
information about the development of surgery generally and as a preferred form
of treating women. This history is also necessary as a foundation for
understanding the comparatively younger surgical specialty of cosmetic
surgery.10 5 Finally, this historical perspective offers insights into present-day
medical/surgical beliefs and conventions regarding physician-patient
relationships, including the surgeon's decisions about how much technical
information he should provide to a woman who is contemplating surgery and
whether he views the woman as an autonomous agent in the decision making
process.10
6
At its inception, gynecology was not a separate specialty, but was instead a
part of abdominal or pelvic surgery.'0 7 Innovations in surgical techniques for
100. See id. at 20.
101. See LILLIAN RANDOLPH, AM. MED. ASS'N, PHYSICIAN CHARACTERISTICS AND DISTRIBUTION IN THE
US, Tables B-3 & B-4 (1997-98) [hereinafter PHYSICIAN CHARACTERISTICS]. In 1991, 8.9% of all surgeons
were women. See Preeti N. Malani, Surgery's Mighty 12,000: Increasingly, the Face Behind the Mask is a
Woman s, 34 AMERICAN MEDICAL NEWS No. 24, at 25 (June 24, 1991); see also Am. Med. Ass'n Council on
Long Range Planning and Development, The Future of General Surgery, 262 J. AM. MED. ASS'N 3178, 3178-
79(1989).
102. In 1996, there were 503 female plastic surgeons and 5,395 male plastic surgeons. See PHYSICIAN
CHARACTERISTICS, supra note 101, Tables B-3 & B-4.
103. See Malani, supra note 101, at 25.
104. See DIANA SCULLY, MEN WHO CONTROL WOMEN'S HEALTH 222-28 (Reissued with a New
Introduction, Teachers College Press 1994) (1980) (discussing the techniques utilized by surgical residents to
convince women to opt for gynecological surgery).
105. Cosmetic surgery for purely aesthetic purposes (separate from reconstructive cosmetic surgery)
developed as surgical technologies were improved:
The emergence of cosmetic procedures in the mid-twentieth century dramatically altered the field of
plastic surgery, marking a new phase in its history. Whereas nearly all plastic surgery in the first part
of the century was done to alleviate deformities due to disease, birth, or mishap, in the second half of
the century this was no longer the case. Plastic surgery began to be performed for the aesthetic
improvement of otherwise healthy bodies and the number of operations increased dramatically.
DAVIS, supra note 66, at 16.
106. See SCULLY, supra note 104, at 91-93.
107. See ANN DALLY, WOMEN UNDER THE KNIFE 7 (1991). Due to its danger, surgery originated as a
primarily external procedure; thus, the early surgeons specialized in skin problems. "Few, if any, dared to open
an abdomen, chest, or skull, even though they knew a good deal about them and what needed to be done when
trouble arose in them." Id. at 8. This was due to the extremely high mortality rate from shock, hemorrhage, or
infection. See id. at 13.
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problems exclusive to women resulted not only in the development of
gynecology as a surgical specialty separate from pelvic surgery, but also in the
development of modem surgery.108 The key surgical innovations included the
ovariotomy and surgical repair of vesico-vaginal fistula, the latter of which was a
result of either protracted childbirth or inept use of instruments by the physician
during childbirth. 109 Thereafter, nineteenth-century pelvic surgeons, as they were
then called, began promoting surgery as the first option for physical and
psychological problems experienced by women." 0
Unfortunately, the pioneer surgeons of the nineteenth century who perfected
these techniques did so at great expense to women, particularly to slaves and
poor immigrants."' For instance, J. Marion Sims, heralded as "the father of
gynecology," perfected the procedure for closing vesico-vaginal fistula while
working from 1845 through 1849 in his small, rural Alabama hospital where he
engaged in medical and surgical experimentation on women. 112 During this four-
year period, he acquired seven slaves from their plantation owners, brought them
to his hospital, and performed repeated operations on them without any
anesthesia. 113 He operated on one of these slaves, Anarcha, who was seventeen
years-old when she first came to his hospital, thirty times before perfecting his
surgical method. 114 The pain Anarcha and the other women endured was
excruciating. 115
108. See id. at 7.
109. See id. at 115-16. The ovariotomy, then referred to as "[e]xtirpation of the [o]varies," involves the
removal of both ovaries and the fallopian tubes. Id. at 16. Today, the procedure is referred to as a "salpingo-
oophorectomy." Id. The surgical repair of vesico-vaginal fistula involves closing "a tear in the wall between the
vagina and bladder." SCULLY, supra note 104, at 30. Before the surgery was developed, women with this
affliction "suffered a continuous seepage of urine which caused severe discomfort, unpleasant odors, and often
ended in social isolation for the victim." Id. Childbirth was also a painful and dangerous experience for women
due to "puerperal fever, or childbed fever," which was a contagious disease "transmitted by hands, clothes, or
instruments to women" in hospitals before the advent of simple antiseptic procedures. Id. at 31. Childbirth
could also result in vesico-rectal fistula, which was a tear between the vagina and the rectum; some women
experienced both the vaginal and rectal fistula. See DALLY, supra note 107, at 22.
110. See SCULLY, supra note 104, at 40.
111. See id at 34, 42 (asserting that historically the disempowered poor have been "used for clinical
observation, experimentation, and instruction"). The author argues that a motivating factor in the decision to
open the first hospital specializing in medical problems exclusive to women in 1851, New York Women's
Hospital, was to "draw for its clientele the impoverished immigrant women who were flooding into New York
City" and thereby ensure "a steady supply of subjects for surgical experimentation." Id. at 45.
112. Id. at42.
113. See id Anesthesia came into general use sometime in 1860. See id at 27.
114. See id at 42-43.
115. See id. at 43. Not only did Sims believe that slaves were better equipped to endure the repeated
pain he inflicted upon them than were Caucasian women, he stated that the pain would have been impossible
for Caucasian women to bear. See id. The truth of the matter is that the slaves did not actually consent to the
surgery, their owners did, See id. During their stay in Sims' hospital, the slaves also became addicted to the
opium that Sims admitted to administering to each of the women in "tremendous quantities." Id. Before the
advent of anesthesia, opium was used in surgery to help counteract the pain. See id. Addiction was not
normally a problem, in the case of a single surgical procedure, but in the case of these women, the continued
experimentation resulted in addiction. Finally, Sims fed, sheltered, and clothed these women, and they were in
no position to resist him, a white man, especially since their owners had provided the necessary consent See id.
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Another surgeon, Ephraim McDowell, was the first to successfully perform
the ovariotomy in his Kentucky home in 1809.116 From 1860 until approximately
the turn of the twentieth century, the ovariotomy was a popular method not only
for removing tumors or cysts or for other types of ovarian disease, but also for
alleged psychological disorders from which women were thought to suffer,
including "nymphomania, and especially for nervous and psychological
problems such as hysteria and 'ovarian insanity."" 17 This operation was
sometimes performed upon women whose husbands procured the surgery as a
cure for their wives' "unruly behavior."118 Women who underwent the procedure
to cure their psychiatric ills were allegedly miraculously transformed into docile,
complacent wives and mothers.119
The ovariotomy as a tool for curing so-called insanity was finally found to
violate the law in one jurisdiction when it was attempted to be used en masse in
a psychiatric hospital:
At a state hospital for the insane in Pennsylvania a separate annex ward was
established for women to have the operation. The surgeons began to operate
and fifty more patients had been "marked for operation" when the committee
on lunacy of the Pennsylvania State Board of Public Charities investigated.
For the first time medico-legal considerations were taken into account. The
committee stated, "The zeal of the gynaecologist is being carried to an
unusual extent when it proposes to use a State Hospital for the Insane as an
experimental station, where lunatic women are to be subject to doubtful
operations for supposed cures." It was felt that if the operation was permitted
on forty or fifty patients, "it might be well to practice [sic] the experiment
upon the entire lunatic population, so that the gynaecologist may have the
large opportunity he doubtless craves to see just what would happen." He
could then "read his conclusions learnedly to his gynaecological brethren,
with the resultant added forward movement up his ladder of fame."'120
It was not until the end of the nineteenth century that the operation when
performed for psychiatric reasons fell into universal disrepute in this country.' 2'
Although the clitoridectomy 122 was a much more controversial procedure within
the nineteenth-century medical community, it was another accepted surgical
116. See DALLY, supra note 107, at 8-9, 16-17. The physician Robert Battey, however, is credited with
popularizing the surgical process, also known as female castration. See SCULLY, supra note 104, at 48.
117. SCULLY, supra note 104, at 49.
118. BARBARA EHRENREICH & DEIRDRE ENGLISH, COMPLAINTS AND DISORDERS, THE SExuAL POLmCS
OF SICKNESS 35 (1973).
119. See id
120. DALLY, supra note 107, at 154.
121. See id. at 155.
122. The term "clitoridectomy" actually describes several different surgical procedures:
An operation on the clitoris may be a true clitoridectomy, in which the entire organ is removed. This
may even be part of a 'vulvectomy', [sic] in which the labia are excised. In Victorian times a popular
word for this was 'extirpation' [sic]. Sometimes the operation done was actually circumcision, the
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method and, like some uses to which the ovariotomy was put, was developed for
correcting something other than disease, female masturbation.'23 This was true
even though the "experts" believed that masturbation was more commonly
practiced by men, and there was no corollary surgical procedure for men or any
record of any man being subject to drastic surgical "correction" of
masturbation. 124 There are no accurate records as to how many of these
procedures were performed in this country, but Dr. W. Gill Wylie, J. Marion
Sims' associate, performed a number of these operations. 125 By 1920, the
clitoridectomy was no longer performed by the vast majority of gynecological
surgeons in the United States.
126
This nineteenth-century surgical orientation and zealous intervention into
otherwise healthy female reproductive organs were harshly criticized by some
medical professionals:
What with burning and cauterizing, cutting and slashing, and gouging, and
spitting, and skewering, and pessarying, the old-fashioned womb will cease
to exist, except in history. The Transactions of the American Medical
Association have figured 123 different kinds of pessaries, embracing every
variety .... They look like the drawings of a turbine water-wheel, or a leaf
from a work on entomology .... I do think that this filling of the vagina with
traps, making a Chinese toy shop of it, is outrageous .... Nowadays, even
our young women must have their wombs shored up, and if a baby
accidentally gets in by the side of the machinery, and finds a lodgement in
the uterus, it may, perchance, have a knitting needle stuck in its eyes before it
has any. 1
27
For the most part, however, the surgeons were lauded for their achievements,
and the failed experiments and the women who endured them were largely
forgotten. 128 The medical community has also demonstrated an unwillingness for
removal of the hood of tissue that surrounds the organ, and sometimes it was infibulation, which is
removal not only of the clitoris but also of the front parts of the labia, done to leave raw parts which
are then sewn together.
1d. at 160. Very little is known about the procedure(s) utilized in this country. See id.
123. See id. at 162. Apparently attitudes toward masturbation have not changed drastically. A study
conducted in 1959 revealed that "half of the medical students and a fifth of the faculty at five medical schools
believed masturbation was a frequent cause of mental illness." SCULLY, supra note 104, at 112.
124. See SCULLY, supra note 104, at 54. Men who masturbated were punished; they were sometimes
required to "wear locked chastity belts by day, and spiked or toothed rings by night, the latter to awaken them
in the case of a nocturnal erection." Id. The only surgical procedure recommended by some physicians for the
treatment of male masturbation was circumcision. See id. The obvious difference in the surgical "remedies"
was that, for men, the procedure did not destroy or eliminate sexual response, and the procedure was less
mutilating and presumably less painful.
125. See id.
126. See id. at 55. One author asserts that the last recorded clitoridectomy was performed in this country
in approximately 1948 "on a child of five, as a cure for masturbation." EHRENREICH & ENGLISH, supra note
118, at 34.
127. DALLY, supra note 107, at 130.
128. See SCULLY, supra note 104, at 38-56.
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critical self-appraisal. Medical reference books from the early twentieth century
to the present, including current gynecological textbooks, have either omitted
any historical reference to the clitoridectomy and ovariotomy (for curing
psychological disorders) or have included only a terse, passing notation of the
procedures. 129 On rare occasions, physicians and other social scientists who have
published books that cast a critical light on the history of the medical profession
have been harshly rebuked by the medical community.13 ° This inability to
tolerate criticism is compounded by the fact that physicians and surgeons have
been and continue to be subject to very limited outside regulation and weak
intemal review and disciplinary procedures.'
31
Many within the medical community downplay this history by arguing that
the physicians of the nineteenth century must be viewed from the perspective of
the social and legal system within which they operated: one in which slavery was
accepted, views on morality and sexuality were vastly different from the present
and one in which women were thought to assume a weak, subservient role in
society.132 It is true that the context within which these physicians pursued their
craft must be understood and examined. It is striking, however, that present-day
parallels exist. For instance, gynecology textbooks exhibit "a persistent
paternalistic and sometimes condescending attitude on the part of the doctor
toward his female patient,"' 133 and surgery remains a first option in
gynecology.
134
One study that was conducted at two teaching hospitals in the mid-1970's
135
revealed that residents become skilled at selling the surgery when it is not
required, but might prove a more efficient, not to mention profitable, option for
129. See DALLY, supra note 107, at 155-56, 160. The available history has been characterized as
"extremely sympathetic to physicians. The patient's role has been largely ignored, the issue of
medical ethics has been vastly underplayed, and critical analyses are almost nonexistent ....
[H]istorians and biographers of the early gynecologists, often themselves members of the medical
profession, glorify these surgeons for their courage and daring use of the knife."
SCULLY, supra note 104, at 39.
130. Seeid. at47-48.
131. See id. at 12-14.
132. See id. at 47.
133. Id. at 107.
134. See Keville, supra note 73, at 131. "'Gynecologists and surgeons remove our female organs with a
lack of concern that is in marked contrast to the respect they display for men's private parts.' Altematives to
surgery (where some treatment is actually necessary) apparently have not been much explored." Id. (footnotes
omitted) (quoting RUTH HUBBARD, THE POLMCS OF WOMEN'S BIOLOGY 17 (1990)); see also SCULLY, supra
note 104, at 17 (citing government statistics that establish the hysterectomy as the most common operation
performed in the United States, outranking the tonsillectomy and appendectomy, the former front runners).
Scully explains the reason for all of the unnecessary surgery in both obstetrics and gynecology, including the
prophylactic hysterectomy, based on the concept of organizational deviance: unnecessary surgery is a medical
organizational norm. See id. at 234-36.
135. The study was conducted by a sociologist who spent three years at two medical centers observing
their training programs in obstetrics and gynecology. See SCULLY, supra note 104, at 1-9. In her study, she
observed the residents at these two medical centers "in labor and delivery rooms, surgical suites, clinics,
classes, and informal gatherings." Id at 1. Although the study is now more than twenty years old, in the
Introduction to the 1994 Edition, Scully observes that many of the same problems and issues persist in
women's health care. See id. at xv-xxvi.
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the doctor.136 The same study also revealed that the poor, minority women who
came to these teaching hospitals were frequently treated with less respect,
allowed to suffer more pain before being treated, and sometimes coerced into a
surgical option when it was not necessary, but provided a learning opportunity to
a resident who either had no experience or very little experience with the
particular surgical procedure. 137 Thus, these women were used as teaching
materials. 138 These residents in gynecology also exhibited a preference for female
patients whom they labeled as "educated" and intelligent, but whom they then
described as "'happy,' obedient, respectful and thankful patients."' 39 In reality,
because the residents placed a premium on patient control, the residents
preferred "malleable and submissive" patients. 1
40
There is no reason to believe that these same residents leave behind their
aggressive surgical attitudes and their desire for compliant patients when they
begin practicing medicine. In fact, the continued emphasis on surgery in
gynecology is supported by the evidence regarding hysterectomies and cesarean
sections: they are performed at a much higher rate in this country than in other
countries with comparable health care systems, and they are often performed
unnecessarily. 141 In fact, cesarean sections, which "replaced the hysterectomy as
the most frequently performed surgery in the United States" by 1981, "vary by
136. See SCULLY, supra note 104, at 191-96. Before residents could actually sell the idea of surgery to
the patients, they had to become skilled at finding patients who fit the residents' training needs. See id. at 219-
22. After locating patients, residents used the following tactics:
The sales pitch used by residents at both hospitals was remarkably similar; in some cases the very
same words were used. The resident opened by moving from a general problem for which a number
of solutions, including doing nothing, were possible, to the solution he was going to try to sell,
usually a hysterectomy. The more supporting evidence that could be brought to bear on the problem,
the more secure the resident was in his pitch. The pitch frequently began when a woman over the
age of thirty-five requested birth control or permanent sterilization in the form of tubal ligation. If, in
addition, the resident could locate evidence of some pathology, he would attempt to sell a
hysterectomy. Essentially, the resident was substituting a hysterectomy (surgery he wanted to do) for
a tubal ligation (surgical scut work). The tactic was similar to the "bait and switch" technique used
in sales in which the advertised item is discredited and another, more expensive, product is
substituted in its place.
Id at 224-25.
137. See id. at 120-40.
138. Seeid at 236-40.
139. Id. at91-92.
140. Id. at 92.
141. See id at 37-38, 140-49; see also Mary Anne Bobinski, Autonomy and Privacy: Protecting
Patients From Their Physicians, 55 U. Prm. L. REv. 291, 302-03 & n.39 (1994). Groups, such as
Hysterectomy Education and Resource Services (HERS), have formed to address concerns about these high
rates of surgery. See KAREN M. IcKs, SuRvivivG THE DALKON SHIELD IUD: WOMEN V. THE
PHARMACEUTICAL INDUSTRY 81 (1994). In this country, surgery of every variety is on the rise and is increasing
"four times faster than the population." SCULLY, supra note 105, at 140. There is a positive correlation between
the number of practicing surgeons and the amount of surgical procedures performed:
In the United States, where there are twice as many surgeons in proportion to the population as in
England and Wales, there is also twice as much surgery. One study found that the rate of surgery in
Kansas was dependent on the supply of surgeons and facilities in a region rather than on the
incidence of disease. Other research has shown that so many physicians are performing surgery that
the work loads of specialists are modest, thus making it difficult for them to maintain their surgical
skills.
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region of the country and by hospital within regions, and rates are higher in the
United States than almost anywhere else in the world."' 142 To a lesser extent,
twentieth-century birth control devices, including Norplant,143 the IUD,'144 and
even birth control pills, 145 similarly require either surgical intervention and
implantation, like the pessary devices of the nineteenth century, or physician
oversight and monitoring, and, because they are products exclusively for women,
their harms are visited solely upon women. 146
Surgical attempts at breast augmentation beginning at the close of the
nineteenth century and continuing to the present represent yet another example
142. SCULLY, supra note 104, at xx; see also Bobinski, supra note 141, at 302-03 & n.39 (citing
"[n]umerous studies" that "have documented variations in the rate of cesarean section deliveries that seem
unrelated to medical necessity"); Margaret M. Donohoe, Our Epidemic of Unnecessary Cesarean Sections:
The Role of the Law in Creating it, the Role of the Law in Stopping it, 11 WIS. WOMEN'S L.J. 197, 197-98
(1996). While eleven other countries have lower rates of cesarean sections than the United States, "only one
industrialized nation for which statistics are available has an infant mortality rate as high as our own." Id. Some
authors argue that the rate at which cesarean sections are performed in this country "has reached epidemic
proportions." Kelly F. Bates, Note, Cesarean Section Epidemic: Defining the Problem-Approaching
Solutions, 4 B.U. PUB. INT'L L.J. 389, 390 (1995).
143. The Norplant birth control device is:
a long-acting method of reversible contraception for women. It consists of six flexible tubes,
surgically implanted beneath the skin of the upper arm, which deliver a sustained low dose of
levonorgestrel, a synthetic progestin. Once absorbed and systemically distributed, the levonorgestrel
dosage works to impede fertility by inhibiting the midcycle hormonal surge necessary for ovulation,
suppressing the cyclic maturation of the inner layer of the uterus, and thickening the cervical mucus
which acts as a barrier to the entry of sperm. Effectiveness begins immediately upon insertion and
continues for five years or until the device is surgically removed. While implanted the failure rate is
approximately equivalent to that of sterilization.
Rachel Stephanie Arnow, The Implantation of Rights: An Argument for Unconditionally Funded Norplant
Removal, 11 BERKELEY WOMEN'S L.J. 19, 20 (1996). A number of side-effects have been found, the most
common of which is "erratic menstrual bleeding." Id. Some of the less common side-effects that have been
documented include "weight gain and increase in appetite, headaches, breast tenderness, ovarian cyst
formation, hair loss or hairiness, dermatitis, acne, and hyperpigmentation or scarring over the implantation
site." Id. For general discussions about the alleged social and legal adverse effects the Norplant device has on
women, particularly poor women and women of color, see Catherine Albiston, The Social Meaning of the
Norplant Condition: Constitutional Considerations of Race, Class, and Gender, 9 BERKELEY WOMEN's L.J.
9 (1994); Jeanne L. Vance, Womb for Rent: Norplant and the Undoing of Poor Women, 21 HASTINGS CONsT.
L.Q. 827 (1994).
144. See HICKS, supra note 141, at 3-4. AnIUD is:
inserted into the uterus via the vagina. The cervix (which connects the vagina to the uterus) must be
stretched with a special instrument during insertion and removal. Most IUD models have tailstrings
attached, which hang down into the vagina and are used to check for proper placement and for
removal. The medical literature is inconclusive on the precise mechanism of IUD action. The ILUD
may prevent fertilization of the egg (if it contains copper or hormones), but, more often, it interferes
with implantation of an embryo. Therefore it can be categorized both as a contraceptive and as a
contragestive device.
Id 1ID devices were originally introduced in the late nineteenth century, but were later abandoned when
many women died of massive infections." Id at 3.
145. See id at 158.
146. See id at 19. Sexism is identified by some scholars as the reason for these types of contraceptive
products:
(1) The contraceptive world is sexist-leaders and researchers are predominately male, and female
methods are their overwhelming focus; (2) the preference is for systemic and surgical methods, as
opposed to barrier methods, which receive 2.2% of funds; and (3) greater concern is shown for
efficacy than for safety, as less than 10% of total expenditures for contraceptive development since
1965 have been devoted to safety.
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of the development of a surgical procedure and the corresponding creation and
use of a medical device through medical experimentation on women. 147 Plastic
surgeons concur in describing the method by which breast augmentation
technology has developed and also admit that "[e]xperiments go on unendingly.
.. 148 The idea for breast implants was generated in 1959, when a medical
resident, who was holding a plastic bag used to store blood, realized that the
blood-filled bag had the consistency of a breast. 149 The first silicone gel-filled
implant surgery was performed in March, 1962, in Houston. 150 The implants
were the creation of Dow Coming product developers who worked in
conjunction with two plastic surgeons.' 51 These implants were larger than the
implants of today, and they were also more firm because the capsule or shell was
thicker and the silicone gel, which was "milky-colored," was also more viscous
than the later-developed implants. 152 Although the procedure was uneventful, no
safety tests involving humans were performed prior to the surgical procedure,
and only limited animal testing had been done.153 Thus, the woman in Houston
was the human guinea pig.
Other women quickly joined her in the experiment, and during the early
1970's several competing manufacturers entered the breast implant market. 154
Each of these competitors was attempting to manufacture and market more
natural looking implants. Development of a thinner implant shell filled with
"more watery silicone gel" was rushed by Dow Coming. 155 Another implant
coated with polyurethane foam and sold by several companies was developed to
prevent the formation of scar tissue and capsular contracture. 156 Both of these
products created problems. Increased rates of rupture and significant gel bleed
occurred with the thinner implants.'5 The polyurethane-coated implants created
another hazard: the foam coating broke down in the breast, producing 2-
toluenediamine (TDA), a substance known to cause cancer in animals.1'5 The
147. See KURT WAGNER & HELEN GOULD, A PLASTIC SURGEON ANSWERS YOUR QUESTIONS: A
PERSONAL CONSULTATION IN BOOK FoRM 80-81 (1972); see also supra notes 88-96 and accompanying text.
148. WAGNER & GOULD, supra note 147, at 80.
149. See RUDOLPH H. GJTHRIE, THE TRUTH ABOUT BREAST IMPLANTS 7 (1994).
150. See BYRNE, supra note 64, at 48.
151. See id. at 47.
152. Id. at 48. The implants came equipped with "small Dacron mesh patches," which were designed so
that the implants "would adhere to the chest muscles to secure the implant without sutures." Id.
153. See id. at 48-49. The animal study involved six dogs, only two of which were monitored for a
period of 18 months. Id at 46-47.
154. See id. at 71-76. By 1975, the Dow Coming monopoly on the breast implant market had fallen to
approximately 35 % of the breast implant market. See id. at 72.
155. Id. at73.
156. See GUTHRIE, supra note 149, at 14.
157. See id. at 62-64; BYRNE, supra note 64, at 76-79.
158. See NANCY BRUNING, BREAST ImPLANTS, EVERYTHING YOU NEED TO KNOW 91 (2d ed. 1995).
TDA was banned from use in hair dyes in 1971 because of its carcinogenicity. See id. One surgeon who used
polyurethane implants for implantation into more than 250 women's breasts observed the following: "[W]ithin
days after surgery about ten percent of the patients developed a fiery, red rash and severe itching that lasted
about two weeks." GUTHRIE, supra note 149, at 15. The surgeon found this to be an allergic reaction. See id.
The polyurethane implant also produced a severe capsular contracture and sometimes the contracture caused
the implant envelopes to break open or rupture at the seams. See id. at 16.
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implants were used by plastic surgeons even though the manufacturers had
performed only limited testing, and some surgeons continued using them after
problems began to surface.159
Another innovation in breast implant technology occurred in the early 1970's
when plastic surgeons began performing breast augmentation surgery under local
anesthesia on an outpatient basis. 160 Prior to this time, the surgery was performed
in a hospital under general anesthesia; patients remained hospitalized for
approximately five days with their arms restrained or bound so they could not
move.161 The new outpatient procedure proved to be very profitable for the
surgeon, allowing for as many as six breast augmentation procedures to be
performed in a single day.162 In order to develop the outpatient technique, some
surgeons retained patients for their experiments by offering the surgery free of
charge. 1
63
Plastic surgeons have also become highly skilled at selling the surgery. In
1983, the American Society of Plastic and Reconstructive Surgeons (ASPRS),
whose membership includes 90% of plastic surgeons in the United States,
initiated a $4 million public relations campaign promoting breast implants by
stating that they were "essential to women's mental health" and that flat-
chestedness caused a "total lack of well being.', 164 Earlier in 1982, the ASPRS
had petitioned the FDA to deregulate implants, arguing that
there is a common misconception that the enlargement of the female
breast is not necessary for maintenance of health or treatment of disease.
There is a substantial and enlarging body of medical information and
opinion, however, to the effect that these deformities [small breasts] are
really a disease which in most patients result in feelings of inadequacy,
lack of self-confidence, distortion of body image and a total lack of well-
being due to a lack of self-perceived femininity. The enlargement of the
female breast, is, therefore, often very necessary to insure an improved
quality of life for the patient.
165
159. See id. at 16-17.
160. See BYRNE, supra note 64, at 64.
161. See id. at 64-65.
162. See id. at 67.
163. See id. at 65. More recently, entrepreneurs who are not doctors have purchased clinics and have
hired surgeons to perform the cosmetic procedures. See HESSE-BIBER, supra note 27, at 52-53. The emphasis
for these business owners is high volume, cost efficiency, and high profit. See id
164. Weisman, supra note 20, at 990 & n. 138. As recently as 1991, the ASPRS marketed a pamphlet
entitled "Straight Talk About Breast Implants," which is no longer distributed, claiming that "breast implants
are among the safest surgically implanted devices in use today. For the vast majority of women, the implant
will come to feel like part of their bodies, occasionally subject to their own special 'illnesses' and injuries."
VASEY & FELDSTEIN, supra note 60, at 97. Not only does this brochure overstate the safety of breast implants,
it also implies somehow that women's bodies may be the cause of any problems associated with the implants.
165. Troutwine, supra note 26, at 49.
[Vol. 9: 15 7
1997] Breast Implants As Beauty Ritual
Around the same time, plastic surgeons invoked the official-sounding
medical term "micromastia ' '166 to describe this newly discovered physical and
psychological malady afflicting women with small breasts. This promotional
tactic was not limited to the ASPRS' strategic attempts to obtain deregulation of
the breast implant market, but was utilized by plastic surgeons who authored
books directed to the consuming public. 167 Plastic surgeons appear to have
internalized the theory that small breasts are a physical deformity, as evidenced
by even a cursory review of medical reference books and textbooks published
before 1992 which are replete with the label "micromastia" and other similar
terminology.
168
The "before" photographs that are offered in these medical texts as proof that
these women are, in fact, diseased reveal that they are simply very thin women
with small frames and correspondingly small breasts.' 69 Thus, like the pelvic
surgeons of the nineteenth century, twentieth-century plastic surgeons created a
psychological ailment peculiar to women that they have linked to a uniquely
feminine body part requiring surgical "correction."'
170
The books written by plastic surgeons for plastic surgery patients before
1992 are also patronizing, condescending, and, above all else, misleading.
171
Women are told that they should expect the implant to become a "permanent
natural part of their body and therefore of the breast structure," that the implants
create breasts which are "not only for real, they're permanent and forever."'
172
Yet, estimates regarding the life span of silicone gel implants range from only
five to fifteen years. 173 This kind of inaccuracy is compounded by the
166. Cohen, supra note 26, at 169 & n. 181. The term appeared as early as 1973 and is defined as
follows:
This condition, also called micromastia, is believed due to a failure of the breast to respond to
hormonal stimulation during the normal maturation phase. Estrogen administration will not
significantly alter the size. There may be gradations in size and shape from the male configuration to
one ofjuvenile female characteristics with apparently normal nipple development.
PLASTIC SURGERY, A CONCISE GUIDE TO CLINICAL PRACTICE 987 (WILLIAM C. GRABB & JAMES W. SMITH
eds., 2d ed. 1973) [hereinafter GRABB & SMITH].
167. See JOHN MCCABE, PLASTIC SURGERY HOPSCOTCH 57 (Miriam Ingersoll ed., 1995).
168. See GABKA & VAUBEL, supra note 80, at 98-99 (referring to a photograph allegedly demonstrating
a "[c]linical view of an extensive hypotrophy of the mamma which was excellently repaired by means of an
augmentation plasty using Dow-Coming epithesis"); GRABB & SMITH, supra note 166, at 987; Another term
utilized to denote small breasts as diseased is "hypomastia," and this term is defined in medical dictionaries as
"atrophy or congenital smallness of the breasts." STEDMAN'S MEDICAL DICTIONARY 836 (26th ed. 1995).
Another apparent synonym utilized to characterize this alleged disease is "hypoplasia," BARRETr, supra note
70, at 388, which is defined as "[u]nderdevelopment of a tissue or organ, usually due to a decrease in the
number of cells," or "[a]trophy due to destruction of some of the elements and not merely to their general
reduction in size." STEDMAN'S MEDICAL DICTIONARY, supra, at 838.
169. See GABKA & VAUBEL, supra note 80, at 99; GRABB & SMITH, supra note 166, at 988; WAGNER &
GOULD, supra note 147, at 86.
170. See supra notes 117-126 and accompanying text.
171. See WAGNER & GOULD, supra note 147, at 80-83.
172. Id. at 81, 83; see also ELIZABETH MORGAN, THE COMPLETE BOOK OF COSMETIC SURGERY, A
CANDID GUIDE FOR MEN, WOMEN & TEENS 348 (1988). Although the title of the book promises honesty, the
author unequivocally states that a breast augmentation procedure will last "[p]ermanently." Id.
173. See Note, supra note 10, at 187-88 & n.130 (citing estimates as low as five to seven years); see
also DAVIS, supra note 66, at 28 (stating that "silicone breast implants need to be replaced after fifteen
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minimization of side effects and the complete omission in many of these books
of silicone-gel bleed and migration as a potential complication. 174 Gel bleed and
migration have been discussed in medical journals since the 1970's; thus, this
omission appears to be a strategic promotional tactic. 175 These omissions and
misstatements are problematic because this kind of information about breast
implants, which has not been readily available to consumers, is the type of
information patients generally rely upon physicians to supply. Moreover, in the
books written for and relied upon by the public, plastic surgeons purport to be
providing accurate and complete information. 1
76
These same books stress that a woman can achieve "normal" breasts through
augmentation surgery, once again sending the message to women with small
breasts that there is something wrong with their bodies, and they equate the
implanted breast with poetry: "[The implanted breast] must have been what
Keats had in mind when he said that a thing of beauty is a joy forever.'' 177 They
glamorize the recovery process and patronize women with their reassurance that
during the two weeks after breast augmentation surgery patients can "read, sleep,
get used to the idea of [their] new body image and enjoy being a Sybarite
generally.' 1
78
Since potential problems with breast implants became public in 1992,
medical publications have, for the most part, stopped describing small breasts as
years."). One study revealed that all implants studied that were more than ten years old at the time of removal
were ruptured. See VASEY & FELDSTEIN, supra note 60, at 96; de Camara, supra note 68, at 829. The former
FDA Commissioner, David Kessler candidly admitted that "[w]e know more about the life span of automobile
tires than we do about the longevity of breast implants." See Note, supra note 10, at 187-88 & n. 130.
174. See WAGNER & GOULD, supra note 147, at 80-81(discussing only capsular contracture as a
possible complication and stressing that "the operation is now so well perfected that there is no reason to wait
on any future improvements"); see also KURT J. WAGNER & GERALD IMBER, BEAUTY BY DESIGN: A
COMPLETE LOOK AT CosMEnc SURGERY 93-96 (1979). In texts that actually mention leakage or gel bleed, it is
treated as a minor clean-up issue: "the result is not harmful to you .... Treatment for this complication is
simple--removal of the gel (it sticks to itself and is pulled out like a string of taffy)." MORGAN, supra note
172, at 361. This last statement is simply not true. "One specialist described the process of removing the
silicone that escapes after an implant ruptures as being 'like picking wet bread from a basin of water."' Cohen,
supra note 26, at 162. It is impossible to remove all of the silicone during an explantation procedure. McCABE,
supra note 167, at 65. Residual silicone will remain "in the breast area and throughout the body." Id
175. See MCCABE, supra note 167, at 57.
176. See id. Prior to 1992, breast implant patients were not provided with the information regarding
many potential side-effects, and this information was not a matter of media attention. See supra note 20. Both
men and women, of necessity rely on their physicians for information regarding medical risks:
As more of daily life becomes medicalized, supposedly morally neutral and objective physicians are
able to make, in the name of health and illness, final judgments that pertain to an ever-increasing part
of human existence. Their unquestioned status as experts has resulted in their almost unprecedented
power over people's lives.
SCULLY supra note 104, at 20.
The very titles of the books written by these surgeons for consumers suggest complete and full disclosure
regarding the surgical procedures. See MORGAN, supra note 172 (The Complete Book of Cosmetic Surgery, A
Candid Guide for Men, Women, & Teens); WAGNER & IMBER, supra note 174 (Beauty By Design: A
Complete Look at Cosmetic Surgery).
177. WAGNER & GOULD, supra note 147, at 81.
178. Id. at82.
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a disease and have ceased to exaggerate the safety of silicone implants. 179 These
texts, however, fail to thoroughly catalogue potential side effects and
complications and mention silicone gel bleed only in passing, usually making no
reference to silicone migration. 180 Some of these texts also assume physician
dominance or actual control over an important aspect of the decision-making
process: the size of the implants. 8 1 These surgeons apparently are not concerned
with their patients' desired results and are instead confident in their ability to
make these very personal decisions for their patients.8 2
In one plastic surgery textbook, a rheumatologist devoted a part of his
discussion to the legal system, labeling the Revised Breast Implant Settlement
Program a "giveaway program.' 8 3  This physician also downplayed the
generalized complaints of fatigue and pain made by many women with breast
implants, attributing their problems to a "hyperirritable state in which fear
predominates. ,184 Consistent with their use of psychology to create a market for
breast implants, it now appears that at least some physicians are utilizing
psychology to explain away problems that women associate with their breast
implants.185  Like their nineteenth-century counterparts, twentieth-century
179. See Jack Waxman, Silicone Fears-How Real Are They?, in 12 ADVANCES IN PLASTIC AND
RECONSTRUCTIVE SURGERY 1-10 (Mutaz B. Habel et a]. eds., 1996); CARLSON, supra note 65, at 107-10. But
see BARRETr, supra note 70, at 388 (discussing the psychological benefits of breast augmentation for women
who suffer from low self-esteem due to breast "hypoplasia").
180. See Waxman, supra note 179, at 1-10; see also CARLSON, supra note 65, at 109-10. One author
advocates warning potential breast implant recipients about many possible side effects, including gel bleed or
leakage, but does not include in this list of side effects the potential for silicone gel that has leaked into breast
tissue to migrate from the breast to other parts of the body. BARRETT, supra note 70, at 395-401. Instead, he
simply advocates warning a patient that "[s]mall microscopic droplets of silicone gel may leak or bleed through
the silicone shell of a breast implant," and that "[t]he long term effects of silicone gel in the body are
unknown." ld. at 398. This warning is insufficient given the fact that silicone gel has been found to migrate to
lymph nodes. See ANGELL, supra note 4, at 41.
181. One text clearly makes the decision the surgeon's:
Implant size is decided upon, and a note is made on the chart. The patient's expectations are
evaluated, and volumes are discussed with the patient. Templates are available showing base
diameter and sizes, and the implant base may be related to these templates to aid the surgeon in
choosing the right implant.
BARRETT, supra note 70, at 395. Women who were interviewed about their experience with breast implant
surgery have confirmed that they were frequently not given a choice as to what their breasts would look like
after the surgery. DAvis, supra note 66, at 129-30.
182. See id
183. Waxman, supra note 179, at 2.
184. Id. at 5. This same physician stated that when women complain of pain and fatigue, "If the implants
are intact in these women, reassurance along with careful examination, proper diagnosis, and appropriate
therapy is needed-not explantation." Id. Apparently, this physician believes that the surgeon should also
control the decision regarding implant removal.
185. See id. Plastic surgery texts often devote sections to discussions of patient selection and how to spot
the potential problem patient. See BARRETr, supra note 70, at xxi-xxv. One plastic surgeon published a list of
twenty different types of problem patients, including a "patient in psychotherapy." Id. at xxiii. This physician,
when discussing another type of problem patient, "the patient whom you dislike," stated:
Unlike psychiatrists-whose work is to deal with many unpleasant emotions, such as hostility-we,
as plastic surgeons, do not need and should not wish to become therapists. Avoid the temptation to
nurture your masochism or megalomania-to want to become an Osler or Freud (they did not
operate on such patients!).
ROBERT GOLDWYN, THE PATIENT AND THE PLASTIC SURGEON 49 (1981). Nowhere in this statement does the
surgeon admit that psychiatry and psychology are outside his field of expertise. Instead, this statement
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physicians and surgeons are not only experts in their respective medical fields,
but are also experts in psychology, and some are apparently well versed in the
law.'8
6
Situated in the proper historical context, breast implants become simply
another in a long line of painful, body-altering beauty rituals, one which is also a
technologically advanced medical product and surgical procedure. When the
focus broadens to the American public and US laws governing women, a larger
lens emerges for this story. An examination of the law in the next section reveals
that the narrative of public opinion, which changed over time by sympathizing
first with the women and then with the manufacturers and surgeons, plays a
crucial part in this story. The doctrine of informed consent and the terms of the
Revised Breast Implant Settlement Program illustrate how the law may in fact
diverge from public understanding about its meaning and how the law reflects
and reacts to public opinion.
IV BREAST IMPLANTS AND THE LAW
The doctrine of informed consent looms large in any legal discussion of
breast implants, whether involving individual lawsuits or the terms of the
Revised Breast Implant Settlement Program. 18 7 An understanding of this legal
doctrine is crucial to assessing the current split and shift in public opinion from a
consumer protective viewpoint to a perspective favoring the manufacturers and
surgeons."88 Although individuals in this latter group, most of whom are
physicians, often argue that it is paternalistic and even sexist to allow women to
recover money from manufacturers or surgeons after they have made a choice to
have breast augmentation surgery,189 implicit in this assertion is the assumption
that these women were given the information necessary to make an informed
choice. This assertion must be examined in light of the requirements of informed
consent.
illustrates how he implicitly assumes he is able to engage in therapeutic activities, including diagnosis and
counseling.
186. This is not to say that psychological concepts have no place in a discussion about breast implants.
For a brief discussion of psychoanalytic theory, social psychology, sociology, and feminist theories regarding
women and their relationships to their bodies, in particular regarding plastic surgery as a feminine beauty ritual,
see DAVIS, supra note 66, at 42-56.
187. In the context of breast augmentation surgery, lack of informed consent, medical malpractice, and
product defect are the most frequently litigated legal theories. See Kathy A. King-Cameron, Comment,
Carving Another Exception to the Learned Intermediary Doctrine: Application of the Learned Intermediary
Doctrine in Silicone Breast Implant Litigation, 68 TuL. L. REv. 937, 963 (1994). The doctrine of informed
consent arises in both the traditional medical treatment situation and in medical research settings. See Sharon
Nan Perley, Note, From Control Over One s Body To Control Over One "s Body Parts: Extending The
Doctrine Of Informed Consent, 67 N.Y.U.L. REv. 335, 338-45 (1992). Different patient interests are at stake
in these two situations. In the medical research or experimentation situation, "informed consent serves a
primarily prophylactic function; through a system of rules and regulations, the doctrine attempts to prevent
harms before they occur." Id. at 342.
188. See supra notes 1-11 and accompanying text.
189. See supra note 19.
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Before examining the doctrine of informed consent, which found its way into
the law as recently as 1957,190 an historical overview of physician attitudes and
practices regarding patient consent is in order. Warnings against disclosing risks
to patients can be traced to Hippocrates:
Perform [these duties] calmly and adroitly, concealing most things from
the patient while you are attending to him. Give necessary orders with
cheerfulness and serenity, turning his attention away from what is being
done to him; sometimes reprove sharply and emphatically, and
sometimes comfort with solicitude and attention revealing nothing of the
patient's future or present condition. 191
This attitude, which found foreign the concept of mutual decision making,
was carried through in Western medical history to the American Medical
Association's (AMA) first ethical Code.192 Although the provisions of the AMA
Code warning against disclosure of medical risks to patients were later
eliminated, the AMA did not explicitly address informed consent requirements
until 1981, and then it created two general exceptions to disclosure: when the
patient was "unconscious or otherwise incapable of consenting" and harm
without treatment was "imminent;" and when disclosure created "such a serious
psychological threat of detriment to the patient as to be medically
contraindicated.' 93 The AMA, however, did not set forth what kinds of
disclosure were required for patient consent, and explicitly limited disclosure
requirements to "the nature and purpose of the treatment undertaken or
prescribed.' 1
94
From the perspective of physicians (as evidenced by AMA pronouncements),
the legal requirements of disclosure and patient consent involve only disclosing
risks and benefits of recommended procedures, not disclosing the available
alternatives, and definitely not disclosing "the certainties and uncertainties
inherent in most treatment options., 195 Thus, informed consent appears to be
nothing more than "an unwitting attempt by physicians to shape the disclosure
190. See JAY KATZ, THE SILENT WORLD OF DOCTOR AND PATIENT 49 (1984); Peter H. Schuck,
Rethinking Informed Consent, 103 YALE L.J. 899, 900 (1994).
191. See KATz, supra note 190, at 4 (quoting 2 HIPPOCRATES, DECORUM 297 (W. Jones trans., Harvard
Univ. Press, 1967)). Hippocrates, author of the Hippocratic Oath, made this statement in the fifth century, B.C.
See id. at 4 & 240 n.5.
192. See id. at 21. The Code, drafted in 1847, admonished doctors to "unite tenderness with firmness,
and condescension with authority, [so] as to inspire the minds of their patients with gratitude, respect and
confidence." Id. The Code also explicitly spoke of the role of the patient: "obedience... should be prompt and
implicit." Id.
193. Id. at 22-23. The earlier statements regarding physician-patient relationships were eliminated in
1903. See id at 22. The explicit discussion of patient consent in 1981 was contained in The Current Opinions
of the Judicial Council, published by the American Medical Association. See id. at 23 & 242 n.43; see also
Anthony Szczygiel, BeyondInformed Consent, 21 OHIO N.U.L. REV. 171, 176 (1994).
194. KATZ, supra note 190, at 23-24.
195. Id. at 26.
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process so that patients will comply with their recommendations. 196 The reasons
offered for this approach to patient consent are that the patient is often incapable
of understanding the complex medical information regarding treatment, that
disclosure of such information will likely confuse and possibly frighten the
patient into inaction when treatment is necessary, and that the physician acts to
convince patients of the proper treatment options with the patient's best interest
in mind. 197 Regardless of whether the physicians' motives are benign and even
protective, their understanding of the requirements of patient consent and actual
practice must be compared with the legal requirements.
The legal doctrine requiring informed consent is premised upon "an
individual's interest in bodily integrity and her concomitant right to self-
determination" and thus mandates that a doctor "disclose all information
material to an individual's decision regarding whether to submit to a particular
medical procedure."' 198 The case law, which has been less than successful in
effectuating this purpose, has developed along two different lines. The first and
majority approach is physician-centered and finds a duty to inform the patient if
physicians in the medical community "customarily inform their patients about
the type of risk involved," or if "a reasonable physician would make the
disclosure in [similar] circumstances." 199 This approach is consistent with the
actual, albeit paternalistic, practice of physicians. 200 The second approach to
informed consent is a patient-centered approach, one in which the standard
applied is that of the "reasonable patient in the plaintiff's position.",20 1 A
physician is, therefore, required to disclose information that would be material to
the reasonable patient's decision.20 2
Under either approach, the plaintiff generally must also establish causation,
that is, the plaintiff must prove that had the information been disclosed, the
plaintiff would not have undertaken the medical procedure. 0 3 Again, the answer
to this latter question is generally based upon an objective standard-whether a
reasonable person in the plaintiff's situation would have declined treatment.
204
Although the reasonable patient test provides more protection than does the
physician-centered approach, it is not a subjective test, and it does not allow the
individual consumer to determine what is relevant to her decision and thus may
196. Id. Some physicians have labeled the informed consent requirements "'quaint"' because of their
belief that "they could always guide the patients to accept the treatment they had selected for them." Id.
197. See id. at 16, 26-27.
198. Perley, supra note 187, at 338.
199. Id. at 341 & n.34 (quoting W. Page Keeton et al., PROSSER & KEETON ON THE LAW OF TORTS § 32,
at 191 (5th ed. 1984)).
200. See supra notes 194-97 and accompanying text; see also Bobinski, supra note 141, at 347
(asserting that the disclosure of provider-associated risks, risks associated with the nature of the physician, "are
unlikely in jurisdictions which have adopted the physician-centered standard").
201. Perley, supra note 187, at 341; see also Schuck, supra note 190, at 916.
202. See Perley, supra note 187, at 341.
203. See id; see also Schuck, supra note 190, at 918-19.
204. See Perley, supra note 187, at 341-42. Only a minority ofjurisdictions have adopted a subjective
test for the causation requirement. See Bobinski, supra note 141, at 346-47.
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deny her a meaningful right of self-determination regarding her own bodily
integrity.2
0 5
Manufacturers of medical devices are, in turn, insulated from liability via the
learned intermediary doctrine.20 6 This legal theory requires that a manufacturer
of a medical device pass along product warnings to the physician, the learned
intermediary, and not directly to the patient.207 If the manufacturer adequately
warns the physician, the manufacturer generally cannot be held liable for the
physician's failure to warn the ultimate consumer of any dangers or risks.20 8 The
cumulative legal effect of informed consent and the learned intermediary
doctrine prior to 1992 was that neither the physician nor the manufacturer were
required to pass along package inserts to prospective silicone breast implant
recipients that described the product's potential dangers.209
These legal doctrines can be very harmful to the breast implant recipient,
given the fact that breast augmentation surgery has never fit the traditional
medical treatment scenario in which a patient receives information about a
medical procedure or treatment from the physician alone.210 Instead, many
women who have undergone breast augmentation have done so after reading
advertising literature provided by the manufacturer, which assures the patient of
product safety directly and fails to mention any harms or side effects.2t1
Like the manufacturer, the surgeon's relationship to the patient is also very
different from the traditional medical treatment model, with many plastic
surgeons advertising their services and having a strong economic interest in the
205. See KATZ, supra note 190, at 82-84. The author eloquently and succinctly summarizes the current
status of the legal doctrine:
[Tjhe law of informed consent is substantially mythic and fairy tale-like as far as advancing patients'
rights to self-decisionmaking is concerned. It conveys in its dicta about such rights a fairy tale-like
optimism about human capacities for "intelligent" choice and for being respectful of other persons'
choices; yet in its implementation of dicta, it conveys a mythic pessimism of human capacities to be
choice-makers. The resulting tensions have had a significant impact on the law of informed consent
which only has made a bow toward a commitment to patients' self-determination, perhaps in an
attempt to resolve these tensions by a belief that it is "less important that this commitment be total
than that we believe it to be there."
Id. (quoting Jay Katz, Informed Consent-A Fairy Tale? Law Nsion, 39 U. Prrr. L. REV. 137, 174 (1977)).
206. See King-Cameron, supra note 187, at 942-43; Susan A. Casey, Comment, Laying an Old
Doctrine to Rest: Challenging the Wisdom of the Learned Intermediary Doctrine, 19 WM. MITCHELL L. REV.
931, 936 (1993).
207. See King-Cameron, supra note 187, at 942.
208. See id. at 943.
209. See id at 963-69. One author asserts that during this time-frame, less than one-third of the doctors
surveyed by researchers mentioned the complications contained in package inserts to their patients. See Note,
supra note 10, at 188. The manufacturers of breast implants have since agreed to provide a "Breast Implant
Information Package" to women considering breast augmentation surgery that includes the following
information: "implant availability, current clinical data, potential medical risks, answers to frequently asked
questions, reimbursement policy, notice of FDA meetings on breast implants, and an extensive bibliography of
related publications compiled by the National Library of Medicine." King-Cameron, supra note 187, at 969-70.
210. See Casey, supra note 206, at 952-54 (comparing breast implants to vaccines and contraceptive
drugs).
211. Seeid. at 954-57.
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patient's decision regarding this elective procedure.212 In assessing patient
consent requirements, it must be remembered that these doctrines were created
for situations involving the treatment of disease and medical conditions, not for
elective surgery upon healthy bodies.213 The law of patient consent in the case of
purely elective, cosmetic surgery must account for the fact that women choose
this type of surgery for subjective, personal reasons and that this choice is a
choice between surgery and no surgery, not a choice between competing medical
treatments.214 Even the patient-centered approach to informed consent becomes
questionable under these circumstances.
Since different motives operate for the patient in purely elective surgery and
different incentives exist for both the physician and manufacturer in the
provision of warnings, informed consent requirements and the learned
intermediary exception to warn may prove inadequate protection for consumers
of breast implants.215 The public needs to know what exactly is meant in the law
by patient consent requirements.216 Public awareness about the differences that
distinguish breast implants from other medical devices and how these
differences interact with the law may very likely influence public opinion
regarding whether these women have been legally wronged.217
The wholesale adoption of these doctrines from other medical device
situations to breast implant litigation may reflect the general lack of public, not
to mention judicial, 218  awareness about what information the medical
community considers to be shielded from laws requiring patient warning.
219
Public assumptions regarding disclosure and warning requirements may also be
at odds with the current state of the law regarding these doctrines, which has
internalized a great deal of paternalism. This may be especially true, given the
cumulative effect of the physician-centered theory of informed consent and the
learned intermediary doctrine.220
The current prevailing public opinion that breast implants do not cause
"harm" may additionally reflect public ignorance, due to lack of knowledge
about just how much information both physicians and manufacturers
consciously failed to supply to women considering breast implant surgery and
212. See King-Cameron, supra note 187, at 970-71; see also Emily C. Aschinger, Note, The Selling of
the Perfect Breast: Silicone, Surgeons, and Strict Liability, 61 LJMKC L. REv. 399, 407-11 (1992).
213. See Casey, supra note 206, at 952.
214. See id
215. Seeid at 952-57.
216. See KATZ, supra note 190, at 82-84. "The legal vision of informed consent, based on self-
determination, is still largely a mirage. Yet a mirage, since it not only deceives but also can sustain hope, is
better than no vision at all." Id. at 84.
217. See Cohen, supra note 26, at 180-82 (discussing the duty to warn in the context of the learned
intermediary doctrine).
218. See Jay Katz, Duty and Caring in the Age of informed Consent and Medical Science: Unlocking
Peabody's Secret, 8 HUMANE MED. 187, 188 (1992). The author asserts that the doctrine of informed consent
was created by judges who incorrectly "assumed that customary medical practice already encompassed shared
decision making." Id. at 188.
219. See KATZ, supra note 190, at 26.
220. See supra notes 199-202, 206-09 and accompanying text.
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the misrepresentations made to women who consulted them personally or read
their literature, prior to 1992.221 Certainly, for those women who have suffered
tangible physical injury after having been under-informed, or even deceived, as
to safety issues, the fact that limited medical testing involving a small number of
specific medical conditions has thus far established no link to breast implants
becomes less important and not entirely relevant to their situations.
222
Moreover, the most frequently articulated arguments against increased
disclosure requirements in medicine are simply not persuasive in the context of
silicone gel breast implants. A general argument made against disclosure of
medical risks is that the average person is incapable of understanding the
complexities involved with medical treatment, medical products, and medical
devices.223 A second argument frequently articulated by scientists and physicians
is that the successful breast implant litigation and the compensation provided by
the Revised Breast Implant Settlement Program, all without hard data of
causation, have a spill-over effect of chilling development of all medical
products for medical treatment contexts, situations in which treatment is
necessary for disease.224 As applied to increased patient warning requirements,
the argument is slightly modified: as a result of all of the warning requirements,
product development will be drastically inhibited and slowed so that
manufacturers and developers can carefully document every conceivable
occurrence and thereby fend off litigation.225
A final argument against increased warnings involves reconstructive surgery
after mastectomy. The argument is premised on a view of breast reconstruction
as not a truly elective procedure.226 There is ample evidence to support the
assertion that many women who have undergone breast reconstruction with
silicone gel implants after losing a breast due to cancer enjoy increased levels of
self-esteem. 227 It is argued that the unfounded scare created with silicone breast
implants and increased warning requirements has and will continue to dissuade
221. See supra notes 8, 164-80, 209 and accompanying text.
222. See supra note 1. The studies assessed the risk for connective-tissue diseases, including rheumatoid
arthritis, systemic lupus erythematosus, Sjogren's syndrome, dermatomyositis, polymyalgia rheumatica,
vasculitis, arthritis associated with inflammatory bowel disease, and polychondritis. See Mayo Clinic Study
supra note 1, at 1698-99.
223. See supra note 197 and accompanying text.
224. See ANGELL, supra note 4, at 82-86; Catherine Baase, Breast Implant Cases More Then Just
Health Issue: The Conflict Between Science and Lawyers Has Far-Reaching Implications, ORLANDO SENT.,
Mar. 16, 1997, at Gl.
225. See Baase, supra note 224.
226. In fact, the FDA ban on silicone gel implants reflects this view. Then Commissioner David Kessler
agreed to allow more ready access to silicone gel implants for women seeking reconstructive breast surgery
than for those seeking cosmetic augmentation, stating that "it makes little sense for the FDA to consider breast
augmentation of equivalent importance with an accepted component of cancer therapy." ANGELL, supra note 4,
at 63.
227. Women who had undergone reconstructive surgery provided vigorous testimony against restricting
or banning silicone implants at the FDA hearings. See id.
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many women who would otherwise have chosen breast reconstruction and will
adversely affect their quality of life.228
None of these arguments are persuasive. The lack of pre-market testing and
the potential side effects previously mentioned, coupled with probable
occurrence rates, to the extent such information is available, is not conceptually
difficult information. 229 There is no reason to believe that women who are
considering breast augmentation surgery are incapable of understanding this
data. As to the argument that advances in medicine will be hindered, the real
problem with silicone breast implants involved gross inadequacies--a complete
failure to test the product on humans before marketing and the additional failure
to warn of known risks with relatively high occurrence rates.230 The types of
product harms, such as rupture, capsular contracture, gel bleed, calcification
formation in breast tissue, to name just a few, are not minor nuisances from this
invasive surgical procedure, but are the very kinds of harms that should be
investigated as a part of product development. It is true that medical
experimentation is a necessary component of technological growth in medicine;
however, the manner of experimentation should be through controlled clinical
trials.23
1
As to the different interests involved in elective and reconstructive breast
augmentation, the argument against increased disclosure is similar to the
argument involving patient abilities to understand warnings: they are both
premised on paternalism in the sense that a woman is deemed to need protection
from technical, medical information because of the belief that she cannot
critically assess the information and make the decision to undergo treatment that
is in her best medical interest. In reality, these assumptions about medical care
are not protective; instead, they deny the woman the right to make her own
decision. If a certain percentage of women who would otherwise elect to undergo
reconstructive breast implant surgery with silicone gel implants now decide, due
to the information regarding both known risks and uncertainties of some risks, to
forego surgery, they have made a more informed decision. In fact, many potential
reconstructive surgery patients object to the continued restriction on silicone
breast implants.232 If these women have been provided with appropriate
warnings, and if the product has undergone sufficient testing and study, breast
reconstruction with silicone implants should be an option.
It is likely, however, that after being warned, a number of women will choose
to forego reconstructive surgery. It is also likely that a number of women, both
those considering elective breast augmentation and reconstructive breast surgery,
228. As one woman stated, "Having my body restored eased away much of the trauma of breast cancer."
Id; see also Is the FDA Protecting Patients From the Dangers of Silicone Breast Implants?: Hearing Before
the Human Resources and Intergovernmental Subcomm. of the Comm. on Gov Y Operations, 101st Cong. 11-
12 (1990) (statement of Rosemary A. Locke, Director, My Image After Breast Cancer).
229. See supra notes 8, 14, 164-80, 209 and accompanying text.
230. See supra notes 66-77, 153 and accompanying text.
231. See supra notes 21, 25.
232. See supra notes 227-28.
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will fail to carefully review the warnings. They should thereafter be held
responsible for their negligent decision making. For those women who decide
not to have the surgery due to fear of even slight risk, so long as the potential risk
is accurately communicated, this result is not bad. It is, in fact, a reflection of
risk-aversion, which varies with the individual.
To use these facts about human nature to require less disclosure is
paternalistic. 233 In other contexts protective, paternalistic laws have long since
been abolished.234 The law presumes that people of a certain age in this society
are adults and are responsible for assessing risks and benefits and making
decisions.235 An exception should not be made in this medical context. Certainly,
the manufacturers and surgeons who misled women about breast implant safety
should not be allowed to hold this paternalistic argument up as a shield.
It bears repeating that in the case of breast implants, not only have
manufacturers advertised directly to women, but in the written warnings
provided with their product prior to 1992, they failed to indicate that long-term
studies had never been conducted on humans before the product was
marketed.236 Under the learned intermediary doctrine, manufacturers in a very
real sense have been rewarded for their lack of sensitivity to safety issues. At a
minimum, women who were contemplating surgery should have been told what
kind of testing had, or in this case, had not been done, so that they could have
made a meaningful choice about whether to assume the long-term risks and
uncertainties of breast implants.
As previously documented, there is also ample evidence that before 1992,
many women were not given either accurate or complete information regarding
233. See supra notes 200, 205 and accompanying text.
234. Courts began striking down protective legislation for working women between 1897 and 1923.
Julie Novkov, Liberty, Protection, and Women's Work: Investigating the Boundaries Between Public and
Private, 21 L. & Soc. INQUIRY 857, 857 (1996). In a 1907 decision, the New York Court of Appeals struck a
state law that limited women's work during night hours, prohibiting their employment between nine in the
evening and six in the morning. See People v. Williams, 189 N.Y 131, 134 (1907). In doing so, the court
expressed its objections in terms of women's rights. The law went "far beyond" a mere limitation on the
number of hours that women could work to interfere with their liberty to select those hours: "It attempts to take
away the right of a woman to labor before six o'clock in the morning, or after nine o'clock in the evening,
without any reference to other considerations." Novkov, supra note 234, at 869 (quoting People v. Williams,
189 N.Y 131, 134 (1907)). Although the same court "reversed itself when confronted with a nearly identical
law in 1915," id., the last vestiges of such protective legislation were eliminated by the Civil Rights Act of
1964. See e.g., Rosenfield v. Southern Pacific Co., 444 F.2d 1219, 1225 (9th Cir. 1971); Ridinger v. General
Motors Corp., 325 F. Supp. 1089, 1096 (S.D. Ohio 1971).
235. This reasoning was also the basis for the decision of the Williams court in 1907:
The court believed that this limitation infringed women's status as full human beings. "If this
enactment is to be sustained, then an adult woman, although a citizen and entitled as such to all the
rights of citizenship under our laws, may not be employed, nor contract to work, in any factory for
any period of time, no matter how short, if it is within the prohibited hours."
Novkov, supra note 234, at 869 (quoting Williams, 189 N.Y at 135). These same reasons apply to medical
situations involving disclosure of risk and patient consent. Dieter Gieson, Ondicating the Patient Rights: A
Comparative Perspective, 9 J. CONTEMP. HEALTH L. & POL'Y 273, 305-06 (1993) (asserting that "the rights
of the patient and not any medical assessment as to his best interests must be the preeminent consideration in
the mind of the treating doctor" and warning that "[t]he days of paternalistic medicine are numbered").
236. See Weisman, supra note 20, at 987-92.
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known risks of breast implant surgery.237 Presumably, the greater the omission in
terms of potential for physical pain or repeated medical treatment, the more
likely it is that a reasonable person would have declined the procedure had she
been informed of the potential side effect or danger. For instance, a woman who
was not warned of the potential for rupture, and was, in fact, actively misled by
physician statements to the effect that her implants would survive if she were
"run over" by "a Mack truck '238 or that she would have "the breasts of an 18-
year-old for the rest of her life,' 239 would likely fare well under the objective
standard. A physician who neglects to warn his patient of the more physically
deforming side effects, such as extreme cases of capsular contracture
accompanied by difficult, painful removal procedures, should also more readily
fail this test of informed consent for the simple reason that cosmetic surgery is
designed to enhance physical appearance.240
In the context of cosmetic breast augmentation, the need to provide the
patient with complete risk information, thereby placing the entire decision in the
patient's hands, is critical for the simple reason that these women are choosing
an elective medical procedure to achieve aesthetic change to their bodies. Even if
these women have severe self-esteem issues about the size or shape of their
breasts, indecision or a decision not to undergo breast augmentation surgery will
not cause them adverse health consequences. This is simply not a situation in
which a learned intermediary, such as a physician, provides or withholds
information to induce the patient to receive necessary medical care. An adverse
decision will only mean that the manufacturers and surgeons will lose a sale of
their product and their service.
Regardless of the level of protection actually afforded, or assumed by the
public to be afforded, to breast implant recipients by legal mandate, the Revised
Breast Implant Settlement Program (Settlement Program), a private settlement,241
237. See supra notes 167-180, 209 and accompanying text.
238. Note, supra note 10, at 187 & n.130.
239. VASEY & FELDSTEIN, supra note 60, at 62.
240. In terms of lawsuits against manufacturers, the case law does not always bear this out. In fact,
according to Dow Chemical Company, over the past 12 years, implant manufacturers have won 69% of all
cases that went to trial. Mark Hansen, Tougher Than the Best, Oregon Judge Refuses to Allow Evidence that
Implants Cause Disease, 83 A.B.A. J. 22, 22 (1997). These negative verdicts may be due in part to a public
perception that women who choose breast implants for cosmetic reasons are making "frivolous,"
"unreasonable, even stupid decision[s]." See Cohen, supra note 26, at 173. The number of lawsuits against
doctors is significantly lower, and doctors are not included in the Settlement Program. Richard L. Cupp, Jr.,
Sharing Accountability for Breast Implants: Strict Products Liability and Medical Professionals Engaged in
Hybrid Sales / Service Cosmetic Products Transactions, 21 FLA. ST. L. REv. 873, 888-89 (1994). The total
number of pending breast implant lawsuits in both federal and state court was estimated in January 1996 to be
approximately 20,000. In Context With Arthur Miller (Court TV broadcast, Jan. 24, 1996).
241. Unlike the Global Settlement, the Settlement Program is not a settlement agreed to by the
defendants and plaintiffs. Mark Curriden, Lawyers Advise Implant Clients to Reject Offer, 82 A.B.A. J. 18, 18
(1996). The "Plaintiff's Settlement Class Counsel" did not approve the terms of the Settlement Program
because they believed "that the settling defendants should have been willing to offer greater benefits, and to
more members of the Lindsey [Settlement Program] class." In re Silicone Breast Implant Prod. Liab., MDL
926, Breast Implant Litigation Notice, 2 (mailed to potential class members in January, 1996) [hereinafter
Settlement Litigation Notice]. Thus, the Settlement Program is a revised settlement offer made by some of the
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provides a certain measure of protection to women with implants.242 It tells yet
another story about the effect of shifting public opinion and possibly the lack of
public awareness of the actual harm suffered by many women with breast
implants, some of whose implants the medical community labeled as intact and
whose breasts the medical community declared healthy.
Under the terms of the Settlement Program, claimants who qualify as
"current claimants '2 43 are not required to establish causation, which means that
they are not required to prove that silicone breast implants caused the diseases
from which they suffer.244 Instead, they are required to establish "that the
qualifying symptoms [for their medical conditions] did not exist before the date
of first implantation., 245 This aspect of the Settlement Program (and its
predecessor, the Global Settlement Agreement) has been harshly criticized and is
the basis for its characterization as a "giveaway program." 246 These criticisms,
which have been widespread and have taken center stage in the media's
presentation of the breast implant controversy over the past several years, could
not help but influence public opinion.247
Yet once again, if this information were accompanied by information
revealing the manufacturers' failure to conduct any lifetime tests prior to the
introduction of the product and during the thirty years before safety questions
became highly publicized, public opinion might be more moderate.248 If the
current media coverage of the issues involved in silicone breast implants
included the fact that the manufacturers made deliberate decisions to market
these devices without thoroughly studying their long-term effects, a different
story would emerge. If the public were also apprised of the manufacturers'
failure to adequately test this product while simultaneously utilizing aggressive
marketing tactics and misleading product literature targeted directly at women,
original defendants from the Global Settlement, which women may choose to accept or reject. See In Context
With Arthur Miller supra note 240.
242. See supra note 12. It was estimated that due to the more than 100,000 projected "current
claimants," substantial "ratcheting" or reduction in projected benefits would be necessary "to perhaps less than
5% of the amounts shown in the original" disease compensation schedule of the Global Settlement. Settlement
Litigation Notice, supra note 241, at 1-2. This "led the Court to conclude not only that thousands of additional
class members would opt out of the class [Global Settlement], but also that the defendants would withdraw
from the settlement as a result of these opt-outs." Id. at 2.
243. Settlement Litigation Notice, supra note 241, at 4-5. These are individuals who qualified under
either the Global Settlement or the Settlement Program as having currently recognized compensable diseases
such as lupus or scleroderma.
244. See id. at 10. The Global Settlement contained a similar provision regarding causation. In re
Silicone Breast Implant Prod. Liab., MDL 926, Breast Implant Litigation Settlement Notice, 5 (mailed to
potential class members in May 1994) (hereinafter Global Litigation Notice]. Although a discussion of
causation in science and law is beyond the parameters of this article, for a discussion of the social construction
of science, see JASANOFF, supra note 16, at 52-53.
245. Settlement Litigation Notice, supra note 241, at Exhibit EI(1)(B).
246. See supra note 189 and accompanying text. This view of the Settlement Program as a "giveaway
program" has also been fueled by the recently released studies finding no causation between silicone breast
implants and connective-tissue disease. See supra note 1.
247. See supra notes 2-3.
248. See supra notes 14, 153 and accompanying text.
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perhaps the public would be more sympathetic to these women.249 Perhaps the
general public would view the no-causation requirement as a trade-off for the
unknown, a trade-off for these women having become, without consent, the de
facto lifetime studies for silicone gel breast implants.
250
Even if public opinion were not entirely sympathetic to these women, if
media coverage were more balanced, or at least more thorough, the public might
very well reserve judgment on this medical and legal situation involving at
present hundreds of thousands of women and potentially many more.251 A very
recent example of the media's unbalanced coverage involves the release of a
medical study in the February 1997 edition of a widely cited international
medical journal, The Lancet.252 The researchers involved in this study assert that
it provides the first medical evidence linking silicone gel breast implants to non-
specific autoimmune conditions that many women claim to experience.253 In
comparison to the widespread multimedia coverage of other recently released
medical studies finding no link between breast implants and various connective-
tissue diseases, this study received limited, one-time newspaper coverage.254
What is most interesting about this disparity in coverage is that the study that
received significantly less media attention involved the physical complaints
many physicians downplay and characterize as either complaints by hysterical
women, or by women who are malleable and easily subject to suggestion, or
even by women who are motivated by fraud.255 Although this type of victim-
249. See supra notes 209-11 and accompanying text.
250. See supra notes 20-21 and accompanying text.
251. It was estimated that more than 440,000 women registered for disease compensation under the
Global Settlement. Mark Curriden, Implant Global Settlement in Jeopardy, 81 A.B.A. J. 34, 34 (1995)
Because the Settlement Program allows women to make claims for disease compensation over the next 15
years (until December 15, 2010), the number of women claiming injuries associated with their implants could
exceed this original number under the prior settlement agreement. See Settlement Litigation Notice, supra note
241, at 5.
252. Scott A. Tenenbaum et al., Use of Antipolymer Antibody Assay in Recipients of Silicone Breast
Implants, 349 LANCET 449, 450-51 (Feb. 15, 1997)
253. Researchers developed a blood test to measure antibodies that they believe may be "markers" for
silicone-related problems. Id. The researchers concluded that, "Our findings suggest that some individuals may
mount a specific antipolymer immune response after exposure to silicone from SBI [silicone breast implants]."
Tenenbaum, supra note 252, at 453. This study has been criticized as being "methodologically flawed."
Stanley A. Edlavitch, Antipolymer Antibodies, Silicone Breast Implants, and Fibromyalgia, 349 LANCET 1170
(April 19, 1997). "The Nurses" Study, see Sanchez-Guerrero, supra note 1, which found no increase in
connective-tissue disease for women with silicone breast implants, was also criticized for other reasons,
including a possible conflict of interest of one of the physicians involved in the research. Today (NBC television
broadcast, reported by Matt Lauer, interviewing Dr. Marcia Angell, June 22, 1995).
254. Terence Monmaney, Study Claims to Link Disease, Breast Implants, L.A. Times, Feb. 15, 1997, at
Al. For the multi-media coverage of the earlier studies, see supra notes 2-3 and accompanying text. For the
newspaper coverage of the current study, see Study Links Illness to Breast Implants, Tests Must Undergo
Scientific Scrutiny, ARIZ. REPUBLIC, Feb. 15, 1997, at A8; New Study May Correlate Breast Implants to
Illness, Hous. CHRON., Feb. 15, 1997, at 1; Study: Implants May Cause Problems, SuN-SENT. FT. LAUD.,
Feb. 15, 1997, at llA.
255. See supra notes 9-10, 190 and accompanying text. These physical complaints that the researchers
studied "include diffuse muscle pain, fever, unremitting fatigue, . . . rashes, alopecia, and neuropathy."
Tenenbaum, supra note 252, at 449; see also Cohen, supra note 26, at 174 (stating that "the legal and medical
systems have often marginalized women's injuries by calling them hysterical rather than physical" (footnote
omitted)).
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blaming is nothing new to women's medical issues, if the media provided more
balanced coverage, the public could decide for itself whether the medical testing
was indeed as conclusive, as so many medical scientists and physicians claim.
256
The details of the Settlement Program have also garnered much less media
interest than had either the Global Settlement or Dow Coming's application for
bankruptcy protection. Pursuant to the terms of the Settlement Program, current
claimants may assert claims according to the "disability/severity levels specified
in the Disease Schedule of the [G]lobal [S]ettlement," but they do so at greatly
reduced rates of recovery.25 If a current claimant chooses instead to make a
claim for the higher level of benefits provided under the Settlement Program, she
must meet more stringent medical criteria.258  Even under the Settlement
Program, the dollar amounts remain significantly lower than they were under the
Global Settlement.
259
An obvious reason for this drastic reduction in benefits is the withdrawal of a
key manufacturer, Dow Coming, who was obligated to contribute nearly half of
the total $4,225,070,000 for the Global Settlement.260  Another pragmatic
consideration for women who have the right to participate in the Settlement
Program is the great cost involved in the alternative in terms of money,
emotional investment, and time; it is estimated that litigation costs for a breast
implant claim range between $100,000 and $200,000 and take between two and
five years, depending upon whether the verdict is appealed.26'
256. The authors of one article found historical support for this type of victim-blaming in a nineteenth-
century medical condition, "hysteria":
Despite these new understandings, the older perception that hysteria was a disorder traceable to the
uterus and was therefore peculiar to women continued to persist both inside and outside the medical
community. Medical definition of hysteria as an authentic illness was undercut by physicians'
simultaneous suspicion that, as Carroll Smith-Rosenberg has argued, the hysterical woman was
likely to be guilty of conscious malingering, "self-indulgence," and "moral delinquency." Even S.
Weir Mitchell, famous for his treatment of hysterical women, described them as "the pests of many
households, who constitute the despair of physicians, and who furnish those annoying examples of
despotic selfishness, which wreck the constitutions of nurses and devoted relatives, and in
unconscious or half-conscious self-indulgence destroy the comfort of everyone about them." Therapy
for hysteria reflected this distrust: it involved isolating the patient from all except the doctor, who
then dominated the patient emotionally. In short, treatment could be punitive.
Martha Chamallas & Linda K. Kerber, Women, Mothers, and the Law of Fright: A History, 88 MICH. L. REv.
814, 825 (1990) (footnotes omitted). A more recent example of a victim-blaming defense tactic involves the
early lawsuits against A. H. Robins, the manufacturer of the Dalkon Shield intrauterine birth control device
(IUD). HICKS, supra note 141, at 1,8 (for an explanation and definition of the IUD, see supra note 139). Not
only did A. H. Robins officials deny wrongdoing and withhold information, they also alleged that the "women's
injuries from the Dalkon Shield were caused by promiscuity and poor personal hygiene, thereby shifting
attention away from themselves and perpetuating a 'blame-the-victim' posture." Id. at 8, 16.
257. Settlement Litigation Notice, supra note 241, at 5 -6; see also Global Litigation Notice, supra note
244, at 6 (these benefits were only estimates or projections).
258. See Settlement Litigation Notice, supra note 241, at 5-8 & Exhibit El.
259. The projected dollar values of the Global Settlement ranged from $105,000 to $1,400,000 for
domestic claimants, depending upon the type of disease and its level of severity. Id. at 1. In contrast, the
maximum benefits payable under the Settlement Program are $253,000. Id at 3.
260. In Context with Arthur Miller, supra note 240 (estimating Dow's contribution to comprise three-
eighths of the total settlement).
261. These estimates are for the cases that would come to trial first. Id. As more of these cases are tried,
it is expected that the cost of litigation will come down slightly. Id.
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The role of the media and its influence upon public opinion, however, cannot
be underestimated in its ultimate ability to shape the terms of the Settlement
Program. As public opinion has shifted over time, the legal pendulum has swung
to favor the manufacturers, and for that matter, the physicians. 262 This shift
occurred long before any of the recently released studies were concluded.263
Such a drastic shift in public opinion would likely give any woman
contemplating her alternatives pause for the simple reason that the general public
comprises a civil juy, and public opinion is a general barometer for a jury's
opinion in the form of its verdict.
264
Another change wrought by the Settlement Program involves the redefining
of diseases, physical harms, and symptoms associated with breast implants,
which are the result of the more stringent qualifying medical criteria.265 Probably
the most significant change involves the heightened level of proof for what were
referred to as "atypical" syndromes or diseases and "non-specific autoimmune
conditions" 266 under the Global Settlement and what are referred to as "general
connective tissue symptoms"'267 under the Settlement Program.
What may be of greater interest are those diseases and symptoms excluded
from the Settlement Program. For instance, cancer is not a disease for which
breast implant recipients may receive compensation. 268 This is true even though
some studies have found a correlation between direct liquid silicone injections
into the breast and cancer.2 6 9 These studies are relevant to silicone gel breast
implants because all implants experience gel bleed into the surrounding breast
tissue.270 Thus, even so-called healthy implants release some silicone into
women's bodies.271 Animal studies have also demonstrated a risk of cancer from
the chemical created by polyurethane-coated implants when they are in direct
262. See supra notes 1-13 and accompanying text.
263. The studies were released in 1994 and 1995. See supra note 1; Angell, supra note 19, at 1696
(calling for the FDA Commissioner, David Kessler, to lift the ban on silicone gel implants in 1992).
264. It is true that historically, "jury verdicts were deemed legitimate precisely because they were
rendered by an independent body and not subject to the influence of popular opinion." Kenneth B. Nunn, When
Juries Meet the Press: Rethinking the Jury's Representative Function in Highly Publicized Cases, 22
HASTINGS CONST. L.Q. 405, 435 (1995). However, ".jlury verdicts must.., be in accord with popular notions
of faimess and justice in order for them to be successfully defended in the arena of public opinion." Id. at 436.
265. See Settlement Litigation Notice, supra note 241, at 5.
266. Global Litigation Notice, supra note 244, at Exhibit D, Disease Schedule.
267. Settlement Litigation Notice, supra note 241, at Exhibit El.
268. See id It was also not covered under the Global Settlement apparently for its "high incidence rate in
the general population." In re Silicone Gel Breast Implant Prod. Liab. Litig., 1994 WL 578353, at *27-28 n.9.
269. See T.H. Chen, Silicone Injection Granulomas of the Breast: Treatment by Subcutaneous
Mastectomy and Immediate Subpectoral Breast Implant, 48 BRIT. J. PLASTIC RECONST. SURG. 71, 71 (1995)
(stating that "silicone leakage from silicone breast prosthesis with or without rupture of the prosthesis is of
great concern"). "Silicone injection for breast augmentation is still common in Asia, even though silicone
injection induced granulomas and associated malignancy have been reported." Id; see also Melvin A.
Shiffman, Silicone Breast Implant Litigation, 13 MED. LAW 681, 685-88 (1994) (listing study results and
arguing that "[t]he occurrence of breast cancer in patients and the fact that they have had silicone injections or
implanted silicone prostheses do not necessarily have a cause and effect relationship").
270. See Marian Segal, Silicone Breast Implants: Available Under light Controls, FDA Consumer 6, 7-
8 (June 1992).
271. See id
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contact with breast tissue. These implants were utilized beginning in the 1970's
and continued until April, 1991 272
When silicone leaks from the implant into the breast tissue, calcifications
develop.273 The greater the silicone leakage, the more prevalent the calcifications
become.274 Even if a woman has her implants removed, this trapped silicone will
remain in her body for the rest of her life.275 The manufacturers who did not
warn women that all implants bleed or leak silicone or of the potential for rupture
or leakage as an implant ages, are not compensating these women for this very
real, permanent alteration and harm to their breast tissue.276 These calcifications
create, at the very least, uncertainty for women and may result in lifetime
mammography problems.
One woman's experience may best illustrate the harms caused by silicone
leakage and calcifications. This woman, who had breast implant surgery in
February of 1983, underwent diagnostic testing in 1995 to determine if her
implants were intact.277 After being told that the state-of-the-art technology for
272. See id It has been estimated that approximately 10% of women with implants have the
polyurethane-coated implants. Id "It is not known whether women with this type of implant have an increased
risk of cancer." Id.
273. Calcifications in breast tissue consist of either microcalcifications or macrocalcifications. Z.
Urbanowicz et al., Calcifications K4sible in Mammographic Examination as a Diagnostic Problem, 67
GINEKOL PoL 366 (1996) (written in Polish, WL Medline Abstract written in English). "Differentiation
between microcalcifications and macrocalcifications is based on variations in size, shape and radiological
changes which they accompany." Id. (quoting Abstract). Microcalcifications can and do occur in breast tissue
of women who have not had either silicone injections or silicone breast implants, id, and "may be indicative of
a cancerous process." Davis v. Caldwell, 429 N.E.2d 741, 743 n.5 (N.Y. 1981); see also R.A. Ersek et al., A
New Biologically, Osmotically, and Oncotically Balanced Gel that Shows Calcifications Blocked by Silicone,
17 AEsTHETIc PLAST. SURG. 331, 334 (1993). In the case of silicone breast implants, the calcifications often
occur in the breast tissue (pocket) surrounding the implant shell. Shiffinan, supra note 269, at 691. The
incidence of calcification is higher with direct liquid silicone injections than with silicone gel breast implants,
and its exact cause for both types of procedures "remains poorly elucidated." Walter Peters and Dennis Smith,
Calcification of Breast Implant Capsules: Incidence, Diagnosis, and Contributing Factors, 34 ANN. PLAST.
SURG. 8, 10, 11 (Jan. 1995). These calcifications are commonly composed of "calcium carbonate-
hydroxyapatite." Id at 10. Sometimes the calcifications "consist of hydrated zinc-calcium phosphate" which
"has never been reported in any other mineralization process related to human disease" and its source "is
thought to be the room-temperature vulcanizing glue that is used in the final sealing process in the manufacture
of these implants." Id. The term "granuloma" is sometimes used to describe noncancerous calcifications when
they consist of "lumps or nodules of inflammatory clls-formed where silicone [has] leaked into [a woman's
body] and combined with tissue." BYRNE, supra note 64, at 93. The term "siliconoma," a synonym for
granuloma, is also occasionally used to denote these calcifications or "tissue reaction[s] to silicone gel
particles." Study: Women with Ruptures have no Greater Incidence of Immune Disease, Cancer, 19 Mealey's
Litig. Rep. 28 (1994). Because calcification is a broader term, used to include granuloma and siliconoma, for
purposes of this article, the term calcification will be utilized throughout.
274. See Bridges & Vasey, supra note 6, at 2641 (comparing gel bleed with gel leakage from a rupture
or defect in the silicone implant and stating that a leak will be "accompanied by a more profound inflammatory
reaction"); see also de Camara, supra note 68, at 831, in which the authors observed that:
The capsules of leaking implants showed inflammation and foreign-body tissue reaction. In the
ruptured group, the response was more intense, with histiocytes, giant cells, and calcification of the
capsule. Masses adjacent to the ruptured implants all showed a similar pattem of foreign-body
reaction with histiocytes. Some of them contained silicone and were calcified.
275. See MCCABE, supra note 167, at 65.
276. See supra notes 8, 14, 153-58, 173, 209, 236 and accompanying text.
277. See Northvestern Memorial Hospital Diagnostic Radiology Report, June 24, 1994 [hereinafter
Ultrasound Report]; Northwestern Memorial Hospital Diagnostic Radiology Report, July 13, 1994
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documenting implant rupture was a breast sonogram or ultrasound test and
magnetic resonance imaging (MRI) of the breast, she underwent both tests and
was told that her implants were not ruptured. 278 Even though the test results were
favorable, she decided to have her implants removed and not replaced.279 The
operative report from the explant surgery told a more vivid story than had either
test:
An incision was made in the inframammary incisions bilaterally and with
the Bovie dissection, carried down to the pocket on the right. This was
opened. The implant was removed. The capsule [implant shell] appeared
intact but there was free silicone around the outside of this, some
calcifications in the pockets but not enough to do a capsulectomy. The
capsule on the pectoral portion was very thin. The pocket [surrounding
breast tissue] on the subglandular portion was thick and had the
calcifications in a milky like material mixed with the silicone ....
Similar procedure was carried out on the opposite side [the other breast]
where similar findings were found. The implant broke on removing it
and it was not broken internally but there was free silicone around it.
280
The significance of this operative report is that it describes the damaged
condition of the breast pocket or tissue surrounding the implants, which prior
testing had found to be intact. Because women were never told about silicone gel
bleed and leakage and implant life span, they were never informed that as their
implants deteriorated over time, they would leave thick calcifications containing
silicone in breast tissue.28' Women were also never told that these calcifications,
which can also be indicative of a cancerous process, might interfere with
mammography.
28 2
This particular woman's subsequent mammography report revealed the
following:
[hereinafter MR[ Report]. This woman does not wish to reveal her identity, but copies of these and other
reports are available from the author of this article with the woman's name redacted.
278. Id see also M.K. Dobke, M.S. Middleton, Clinical Impact ofBreast Implant Magnetic Resonance
Imaging, 33 ANN. PLAST. SURG. 241, 241 (1994) (stating that MRI is the state-of-the-art technique for
diagnosing implant rupture); Ultrasound Useful in Detecting Breast Implant Ruptures, Cancer Researcher
Weekly, May 23, 1994, at 12 (asserting ultrasound as 94% accurate in detecting implant rupture).
279. To be precise, the first test, the ultrasound, revealed a "possible intracapsular rupture" of the left
breast implant. Ultrasound Report, supra note 277, at 1. An MRI was recommended to determine if the
implant was ruptured. Id. at 2. The subsequent MRI test revealed no evidence of rupture. MRJ Report, supra
note 277.
280. Northwestern Memorial Hospital Procedure Report, June 14, 1995 [hereinafter Procedure
Report].
281. See supra notes 171-175, 209, 238-39 and accompanying text.
282. Ersek, supra note 273, at 331.
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There are large collections of bizarre macrocalcifications and benign-
appearing, tightly grouped microcalcifications within the central
posterior aspects of both breasts that are consistent with residual capsular
calcifications from the patient's previous bilateral likely subglandular
breast implants. There is no obvious free silicone identified. However,
evaluation for residual silicone ... is made difficult given these extensive
bilateral calcifications. . . . Elsewhere throughout both breasts are
scattered and occasionally groups [of] benign appearing punctate
microcalcifications. Given the fact that there are multiple randomly
distributed similar appearing groups of this calcification throughout both
breasts, supports a benign etiology ....
No specific radiographic features of malignancy are identified. Changes
are noted consistent with a history of status post bilateral breast implant
removal. There are numerous chunky calcifications within the posterior
aspects of both breasts that are consistent with residual benign capsular
calcifications, status post breast implant removal ....
It is strongly recommended that the patient's previous outside
mammograms... be obtained for comparison to insure the stability of
these findings.28 3
After compared to previous mammogram testing, the radiologist concluded,
that the comparison was "not particularly useful given the presence of pre-
pectoral silicone implants at the time of the 1989 [mammogram] study.,284 The
radiologist also stated that one reason for a failure of the calcifications to appear
on the 1989 mammogram screening could "in part be due to previous
obscuration by the implants. 285 The radiologist's final recommendation was for
yearly "mammographic follow-up, scheduled as a diagnostic examination. '" 28
6
Prior to 1992, women were not told that even after implant removal, their
breasts and bodies would forever contain silicone and these calcifications. 287 At
the very least, every woman contemplating breast augmentation surgery has a
right to know that these calcifications, when viewed by a radiologist reading a
mammogram, often look like cancerous tumors and that the silicone implant can
"block or distort mammograms, causing a lump to go undetected at the early
stage of cancer when it is still small., 288 "According to some studies, early
detection through mammography reduces the rate of death from breast cancer by
283. University of Chicago Hospitals Radiology Consultation Report, November 8, 1996 [hereinafter
Mammogram Report].
284. University of Chicago Hospitals Radiology Consultation, January 7, 1997, at 1.
285. Id.
286. Id. at 2.
287. McCABE, supra note 167, at 65.
288. Cupp, supra note 240, at 886 & n. 106; see also Shiffman, supra note 269, at 691.
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30 percent to 50 percent., 289 These harms are not discussed by either the medical
profession or the media when scientists, physicians, and surgeons unequivocally
state that breast implants do not cause disease. Neither is this physical damage to
breast tissue or the resulting difficulty with mammography compensated under
the Settlement Program.
290
Increased benefits for implant rupture are only available under the Settlement
Program if women who claim to be suffering from a disease currently recognized
under either the Settlement Program or its predecessor, the Global Settlement,
can also establish that at least one of their implants was ruptured at the time of
removal. 291 There are, thus, no available benefits for proof of rupture without a
documented disease.292 Thus, rupture itself is not a recognized compensable
harm under the Settlement Program. 293 This fact is especially unfortunate for
those women whose breast tissue immediately surrounding the implant, the
capsule, has become "heavily calcified. 294 For some of these women, not only
must their ruptured implants be removed, the surgeon must also excise nearly all
of the remaining breast tissue.295 In order to retrieve as much silicone as possible,
surgeons have sometimes been required to go "deep into the rib cage and scrape
it out."' 29 6 The pain accompanying these procedures is much more intense than
with the original implantation surgery.
297
Women are also not compensated under this Settlement Program for other
physical damage, including severe, deforming capsular contracture.298 Instead, a
small amount of money is provided for removal of the implants. 299 This amount
may not cover the entire cost of removal and does not include compensation for
the additional scarring and pain associated with another surgical procedure.
300
289. Caroline W. Jacobus, Legislative Responses to Discrimination in Women 's Health Care: A Report
Prepared for the Commission to Study Sex Discrimination in the Statutes, 16 Women's Rts. L. Rep. 153, 300
(1995).
Mammography is presently the best method of detecting breast cancer at its earliest stages-before
the cancer has spread and often before the tumor can be felt. Detecting the cancer this early means a
higher chance of survival and perhaps less drastic surgery. One study estimates that for women 50
and over, physical examination alone has reduced deaths due to breast cancer by 18[%], but physical
exam combined with annual mammography screening reduced breast cancer mortality by 56[%].
Peter J. Thill, Note, Insurers' and Courts' Response to High Dose Chemotherapy with Autologous Bone
Marrow Transplant in the Treatment of Breast Cancer: A Tragedy or Necessity?, 43 DRAKE L. REv. 863, 865
n.9 (1995) (quoting Judith Willis, Why Women Don k Get Mammograms (And Why They Should), FDA
CONSUMER, May 1987, at 5).
290. See Settlement Litigation Notice, supra note 241, at 4-12.
291. See id. at 6.
292. See id. at 5.
293. See id.
294. BYRNE, supra note 64, at 159.
295. See id.
296. Id at 158.
297. See id. at 158-59.
298. For an explanation of capsular contracture, see supra notes 68-70 and accompanying text.
299. The Settlement Program provides women with $3,000.00 as a one-time explantation fee upon
documentation that they have had their implants removed. Settlement Litigation Notice, supra note 241, at 4.
300. For some women, the estimate of implant removal costs is as high as $25,000.00. See Curriden,
supra note 241, at 18.
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For those women who were not informed that capsular contracture might occur
or that their implants would deteriorate over time and eventually require
replacement, the Settlement Program is inadequate in this respect.
The Settlement Program does not compensate for another side effect that can
result from repeat surgical procedures-nerve damage and numbness to the
nipples and breast tissue.30 1 This is a very real and significant harm to a woman
who has lost in part her potential for sexual arousal and whose joy in her own
body has been diminished. If the legal system generally provides compensation
for emotional pain and suffering and for loss of sexual enjoyment due to personal
injury, why were women not provided even modest sums under the Settlement
Program for these harms to their bodies?302 A similar argument can be made for
another very real physical harm to women's breasts: some women lose the ability
to breast feed their babies.30 3 Again, many women were not warned of this
potential side effect which causes tangible, physical harm and emotional pain.3t 4
The harm resulting for these women is three-fold. First, they have been
harmed by the misleading, inaccurate information provided by both
manufacturers and physicians when they made their decisions to undergo breast
augmentation surgery. Next, they have been harmed because their significant
physical injuries have not been recognized by even minimal compensation under
the Settlement Program. Finally, they have been harmed by the one-sided
presentation of the issues by the media, which has never focused on these types
of injuries, their rate of occurrence, the failure to warn, and the failure to
compensate under the Settlement Program.
The failure to acknowledge these harms through balanced media coverage
and even modest monetary settlement benefits amounts to sanctioning "medical
violence" against women.305 The message to these women and to society is that
301. See DAvis, supra note 66, at 27-28; Settlement Litigation Notice, supra note 241, at 4-12. It is true
that this harm is a direct result of surgery, but if the repeat surgical procedure is due to a failure to warn about
the nature of the product in terms of rupture or lifespan, there is a strong basis for manufacturer responsibility.
302. See generally David W. Leebron, Final Moments: Damages for Pain and Suffering Prior to
Death, 64 N.YL. Rev. 256, 263 (1989) (discussing damages for "possible loss of sexual function" in action
involving "partial or complete paralysis of a victim"); Joy Lazo, Comment, True or False: Expert Testimony on
Repressed Memory, 28 Loy. L.A.L. REv. 1345, 1355 & n.55 (1995) (discussing damages for sexual
dysfunction in repressed memory, childhood sexual abuse claim); Linda Jorgenson, et al., The Furor Over
Psychotherapist-Patient Sexual Contact: New Solutions to an Old Problem, 32 WM. & MARY L. REV. 645,
712-13 (1991) (reviewing implications of claim involving allegations of emotional harm resulting in sexual
dysfunction). Damage awards for loss of sexual functioning or enjoyment are also made based upon a
derivative claim of a spouse or partner-loss of consortium claims. See Katharine Silbaugh, Turning Labor
into Love: Housework and the Law, 91 Nw. U.L. REv. 1, 42-43 (1996) (discussing generally the evolution of
the claim of loss of consortium from an exclusively male right to one including women).
303. See supra notes 73-75 and accompanying text.
304. Id.
305. This phrase is borrowed from Karen Hicks in her discussion of the Dalkon Shield controversy and
A.H. Robins' treatment of the women who were injured by its product. See HICKS, supra note 141, at 15. She
defines medical violence as "all needless operations, misdiagnoses, and failed medical interventions performed
on victims with less social power than medical professionals. Medical violence reflects and reinforces
patriarchal values and social structures. It also results in an enormous profit to the medical elites and in great
cost, both physical and financial, to the victims." Id. In the context of this discussion, medical violence refers to
the negligent, deceptive marketing of this product and the surgery accompanying its use and the resulting
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these are not harms, but rather acceptable occurrences.30 6 When the media
oversimplifies such issues into black and white sound-bytes while currently
transmitting the message that silicone breast implants are medically safe devices,
not only are many women harmed, but the public also loses something-its
ability to make informed judgments about these issues of disease and physical
harm.
V CONCLUSION
Somewhere along the way, the story of silicone gel breast implants has lost
its focus, has become skewed. The current focus has narrowed to a limited
number of connective-tissue diseases that thus far have not been scientifically
linked to breast implants. Women claiming symptoms of these and other diseases
are being sent very clear messages. If they suffer from a recognized condition
such as lupus, they are being told that even though the Settlement Program will
compensate them for their condition, their implants were not the cause of that
condition. If they suffer from generalized complaints of fatigue, muscle and joint
pain, memory loss, and other symptoms, 30 7 they are told their condition is
psychosomatic or even non-existent and fraudulently motivated.
Women, who are valued for their physical beauty,30  and who were
aggressively, not to mention deceptively, targeted for this cosmetic surgical
procedure, are now being condemned after undergoing this beautification ritual.
Consequently, in a very real way, silicone gel breast implants have become
"woman's sceptre and prison."309 Both the breast implant recipients and the
physical and emotional harm suffered by women, most of which has not been compensated by the Settlement
Program. While it is understandable that the resources provided under the Settlement Program are limited, it is
astonishing that these harms are not recognized through even nominal settlement amounts.
306. In fact, there is evidence that members of the medical community treat these very real harms in this
manner. For example, in her book, Dr. Angell states, "Difficulty in performing mammography is a fourth
problem. It is not exactly a complication, but a necessary concomitant of having breast implants." ANGELL,
supra note 4, at 42. If women were not warned of this "necessary concomitant," and if they would have not
chosen breast implants had they been provided with this information, then they have been harmed.
307. See Mark Ballard, Class Action Implant Trial Opens in Big Easy, NAT'L L.J., Mar. 31, 1997, at
A10 (discussing these symptoms and allegations of silicone migration to the "liver, spleen and brain stem" in
the context of the class action trial currently underway against Dow Chemical Corporation in New Orleans).
308. See generally Toby Mark Miller et al., Survey on Body Image, Weight, and Diet of College
Students, 77 J. AM. D-ETIc ASS'N 561, 561 (1980) (discussing "the overwhelming emphasis on beauty in
our society, and our preoccupation with appearance" in the context of weight issues).
309. One study of jury verdicts in breast implant cases may provide an explanation:
A total of 17 product liability verdicts in silicone and saline breast implant cases were awarded
between January, 1970 and March, 1994. Plaintiffs prevailed in 11 of these cases, for an overall
success rate of 65 percent. Twelve of the seventeen decided cases were brought by plaintiffs who
used the implants for cosmetic breast augmentation. Of these, only six (fifty-five percent) of the
cases resulted in plaintiff victories. In contrast, plaintiffs prevailed in four out of the five (eighty
percent) cases filed by women whose implants were inserted as part of breast reconstruction surgery.
This suggests that gender stereotypes of the "good" and "bad" woman play a role in the outcome of
the cases.
Thomas Koenig & Michael Rustad, His and Her Tort Reform: Gender Injustice in Disguise, 70 WASH. L.
REv. 1, 43-44 (1995) (footnotes omitted). For another statistical study of breast implant verdicts in more
recently tried cases, see Hansen, supra note 240, at 22.
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general public deserve more complete, accurate information about important
medical questions: Are breast implants safe enough? And who should bear the
burden of proving harm, or, for that matter safety, when, for instance, state-of-
the-art medical technology demonstrates no rupture, but upon removal it
becomes apparent that the implants have leaked silicone into the woman's breast
tissue that will forever remain in her breasts making mammography and cancer
detection difficult?
310
One answer likely to be provided by the manufacturers who have agreed to
the terms of the Settlement Program is that they did so not as an admission of
liability or wrongdoing but to avoid paying multimillion dollar jury verdicts.311
Certainly, the studies showing no link between connective-tissue diseases and
breast implants are relevant to lawsuits in which liability was premised upon the
breast implants causing these diseases.312 This refrain that the recently released
studies conclusively establish no wrongdoing is, however, misleading because
these manufacturers and surgeons have committed numerous other wrongs
resulting in physical harm for which hundreds of thousands of women will never
be compensated.
310. See supra notes 287-89 and accompanying text. Current technology for measuring the integrity of
the silicone gel breast implant shell includes in vitro measurement. See Yu, supra note 17, at 762.
311. See Settlement Litigation Notice, supra note 241, at 11, in which it is clearly stated that "the
settling defendants continue to deny any wrongdoing or any legal liability of any kind."
312. For a discussion of one of these cases, see Hopkins v. Dow Coming Corp. 33 F.3d 1116 (9th Cir.
1994). In this case, the plaintiff alleged that she suffered from mixed connective-tissue disease, "a
rheumatological disorder which includes symptoms such as extreme fatigue, weakness, muscle aches and
pains, arthralgia, myalgia, and arthritis." Id at 1118. The plaintiff was awarded $840,000.00 in compensatory
damages and $6.5 million in punitive damages, and this award was upheld on appeal. Id. at 1119-20, 1128.
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